<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?>
<?SourceDTD.Version 1.3?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Pharmaceutics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Pharmaceutics</journal-id>
    <journal-id journal-id-type="publisher-id">pharmaceutics</journal-id>
    <journal-title-group>
      <journal-title>Pharmaceutics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1999-4923</issn>
    <publisher>
      <publisher-name>MDPI</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8779003</article-id>
    <article-id pub-id-type="doi">10.3390/pharmaceutics14010122</article-id>
    <article-id pub-id-type="publisher-id">pharmaceutics-14-00122</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>SCMTHP: A New Approach for Identifying and Characterizing of Tumor-Homing Peptides Using Estimated Propensity Scores of Amino Acids</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Charoenkwan</surname>
          <given-names>Phasit</given-names>
        </name>
        <xref rid="af1-pharmaceutics-14-00122" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2984-3330</contrib-id>
        <name>
          <surname>Chiangjong</surname>
          <given-names>Wararat</given-names>
        </name>
        <xref rid="af2-pharmaceutics-14-00122" ref-type="aff">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1040-663X</contrib-id>
        <name>
          <surname>Nantasenamat</surname>
          <given-names>Chanin</given-names>
        </name>
        <xref rid="af3-pharmaceutics-14-00122" ref-type="aff">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0756-1006</contrib-id>
        <name>
          <surname>Moni</surname>
          <given-names>Mohammad Ali</given-names>
        </name>
        <xref rid="af4-pharmaceutics-14-00122" ref-type="aff">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lio’</surname>
          <given-names>Pietro</given-names>
        </name>
        <xref rid="af5-pharmaceutics-14-00122" ref-type="aff">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0697-9419</contrib-id>
        <name>
          <surname>Manavalan</surname>
          <given-names>Balachandran</given-names>
        </name>
        <xref rid="af6-pharmaceutics-14-00122" ref-type="aff">6</xref>
        <xref rid="c1-pharmaceutics-14-00122" ref-type="corresp">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3394-8709</contrib-id>
        <name>
          <surname>Shoombuatong</surname>
          <given-names>Watshara</given-names>
        </name>
        <xref rid="af3-pharmaceutics-14-00122" ref-type="aff">3</xref>
        <xref rid="c1-pharmaceutics-14-00122" ref-type="corresp">*</xref>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Szlęk</surname>
          <given-names>Jakub</given-names>
        </name>
        <role>Academic Editor</role>
      </contrib>
      <contrib contrib-type="editor">
        <name>
          <surname>Pacławski</surname>
          <given-names>Adam</given-names>
        </name>
        <role>Academic Editor</role>
      </contrib>
    </contrib-group>
    <aff id="af1-pharmaceutics-14-00122"><label>1</label>Modern Management and Information Technology, College of Arts, Media and Technology, Chiang Mai University, Chiang Mai 50200, Thailand; <email>phasit.c@cmu.ac.th</email></aff>
    <aff id="af2-pharmaceutics-14-00122"><label>2</label>Pediatric Translational Research Unit, Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand; <email>wararat_01@yahoo.com</email></aff>
    <aff id="af3-pharmaceutics-14-00122"><label>3</label>Center of Data Mining and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok 10700, Thailand; <email>chanin.nan@mahidol.edu</email></aff>
    <aff id="af4-pharmaceutics-14-00122"><label>4</label>Artificial Intelligence &amp; Digital Health Data Science, School of Health and Rehabilitation Sciences, Faculty of Health and Behavioural Sciences, The University of Queensland, St Lucia, QLD 4072, Australia; <email>m.moni@uq.edu.au</email></aff>
    <aff id="af5-pharmaceutics-14-00122"><label>5</label>Department of Computer Science and Technology, University of Cambridge, Cambridge CB3 0FD, UK; <email>pl219@cam.ac.uk</email></aff>
    <aff id="af6-pharmaceutics-14-00122"><label>6</label>Department of Physiology, Ajou University School of Medicine, Suwon 16499, Korea</aff>
    <author-notes>
      <corresp id="c1-pharmaceutics-14-00122"><label>*</label>Correspondence: <email>bala@ajou.ac.kr</email> (B.M.); <email>watshara.sho@mahidol.ac.th</email> (W.S.)</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>04</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <volume>14</volume>
    <issue>1</issue>
    <elocation-id>122</elocation-id>
    <history>
      <date date-type="received">
        <day>12</day>
        <month>11</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>28</day>
        <month>12</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2022 by the authors.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p>Tumor-homing peptides (THPs) are small peptides that can recognize and bind cancer cells specifically. To gain a better understanding of THPs’ functional mechanisms, the accurate identification and characterization of THPs is required. Although some computational methods for in silico THP identification have been proposed, a major drawback is their lack of model interpretability. In this study, we propose a new, simple and easily interpretable computational approach (called SCMTHP) for identifying and analyzing tumor-homing activities of peptides via the use of a scoring card method (SCM). To improve the predictability and interpretability of our predictor, we generated propensity scores of 20 amino acids as THPs. Finally, informative physicochemical properties were used for providing insights on characteristics giving rise to the bioactivity of THPs via the use of SCMTHP-derived propensity scores. Benchmarking experiments from independent test indicated that SCMTHP could achieve comparable performance to state-of-the-art method with accuracies of 0.827 and 0.798, respectively, when evaluated on two benchmark datasets consisting of Main and Small datasets. Furthermore, SCMTHP was found to outperform several well-known machine learning-based classifiers (e.g., decision tree, k-nearest neighbor, multi-layer perceptron, naive Bayes and partial least squares regression) as indicated by both 10-fold cross-validation and independent tests. Finally, the SCMTHP web server was established and made freely available online. SCMTHP is expected to be a useful tool for rapid and accurate identification of THPs and for providing better understanding on THP biophysical and biochemical properties.</p>
    </abstract>
    <kwd-group>
      <kwd>tumor-homing peptide</kwd>
      <kwd>therapeutic peptide</kwd>
      <kwd>scoring card method</kwd>
      <kwd>propensity score</kwd>
      <kwd>machine learning</kwd>
      <kwd>bioinformatics</kwd>
    </kwd-group>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="sec1-pharmaceutics-14-00122">
    <title>1. Introduction</title>
    <p>Tumor-homing peptides (THPs) are short peptides ranging in size from 3 to 30 residues that specifically target tumor cells [<xref rid="B1-pharmaceutics-14-00122" ref-type="bibr">1</xref>]. THPs may be used in the near future for tumor diagnostic and therapeutic applications due to their low antigenicity, lack of significant cytotoxicity to normal cells, rapid incorporation into target cells as well as their ease of modification and redesign [<xref rid="B2-pharmaceutics-14-00122" ref-type="bibr">2</xref>]. THPs’ motifs frequently contain RGD (Arg-Gly-Asp) and NGR (Asn-Gly-Arg), which are known to favor receptor-mediated interaction in cancer cell recognition with high specificity and low cross-reactivity [<xref rid="B3-pharmaceutics-14-00122" ref-type="bibr">3</xref>,<xref rid="B4-pharmaceutics-14-00122" ref-type="bibr">4</xref>]. Furthermore, the RGD function is compatible with KGD [<xref rid="B5-pharmaceutics-14-00122" ref-type="bibr">5</xref>], RYD [<xref rid="B6-pharmaceutics-14-00122" ref-type="bibr">6</xref>] and RHDS [<xref rid="B7-pharmaceutics-14-00122" ref-type="bibr">7</xref>] motifs in integrin binding sites [<xref rid="B8-pharmaceutics-14-00122" ref-type="bibr">8</xref>]. Hundreds of THPs could identify tumors in vivo and deliver anticancer drugs to the tumor site, thereby resulting in cancer treatment and diagnosis [<xref rid="B9-pharmaceutics-14-00122" ref-type="bibr">9</xref>]. THPs were developed as a targeted vehicle for gene therapy of solid tumors such as the sodium-iodide symporter (NIS) [<xref rid="B10-pharmaceutics-14-00122" ref-type="bibr">10</xref>]. So far, several THPs have been experimentally tested in clinical trials. For example, in a phase I/II trial testing for safety and immunogenicity, a multipeptide vaccine (IMA950) formulated the nine antigens by peptide elution from the surface of glioblastoma [<xref rid="B11-pharmaceutics-14-00122" ref-type="bibr">11</xref>,<xref rid="B12-pharmaceutics-14-00122" ref-type="bibr">12</xref>]. THPs’ experimental characterization, on the other hand, is still a time-consuming and labor-intensive endeavor. As a result, approaches based on machine learning (ML) that can accurately identify THPs based on primary sequence information would be beneficial. Furthermore, these methods may reveal important information about THPs’ functional mechanisms.</p>
    <p>To the best of our knowledge, only two computational methods in the field have been made (TumorHPD [<xref rid="B13-pharmaceutics-14-00122" ref-type="bibr">13</xref>] and THPep [<xref rid="B14-pharmaceutics-14-00122" ref-type="bibr">14</xref>]). These two approaches have been developed to identify THPs solely based on their sequence information (e.g., amino acid composition (AAC) and dipeptide composition (DPC)). Sharma et al. [<xref rid="B13-pharmaceutics-14-00122" ref-type="bibr">13</xref>] proposed the first THP predictor (TumorHPD) in 2013, which was created using a support vector machine (SVM) algorithm in conjunction with AAC, DPC and binary profile patterns (BPP). Furthermore, in this research work Sharma et al. shared two benchmark datasets namely Main and Small datasets. Our group proposed the second THP predictor (referred to as the THPep [<xref rid="B14-pharmaceutics-14-00122" ref-type="bibr">14</xref>]) by combining the use of the random forest (RF) algorithm with three popular sequence-based feature descriptors (e.g., AAC, DPC and pseudo amino acid composition (PAAC)). THPep was found to improve the overall performance in terms of accuracy (ACC), sensitivity (Sn), Matthew’s Correlation Coefficient (MCC) and area under the receiver-operating curves (AUC) when compared to TumorHPD (i.e., as measured by the cross-validation test on the two benchmark datasets) [<xref rid="B13-pharmaceutics-14-00122" ref-type="bibr">13</xref>]. Although the performance of these two existing THP predictors was generally good, there was a strong need for new approaches that can yield good prediction performance while also providing biologists mechanistic interpretation of tumor homing activities of peptides that can be used for guiding the design of robust peptides.</p>
    <p>To address the aforementioned issues, we have developed SCMTHP as a novel, simple and interpretable method for in silico identification and characterization of peptide tumor homing activities using primary sequence information. <xref rid="pharmaceutics-14-00122-f001" ref-type="fig">Figure 1</xref> summarizes the SCMTHP schematic framework for THP identification and characterization. Particularly, the major contributions of SCMTHP can be summarized as follows.</p>
    <list list-type="order">
      <list-item>
        <p>To the best of our knowledge, SCMTHP is the first propensity score-based predictor that is employed to create and optimize several new propensity scores of 20 amino acids in becoming THPs via the scoring card method (SCM) [<xref rid="B15-pharmaceutics-14-00122" ref-type="bibr">15</xref>,<xref rid="B16-pharmaceutics-14-00122" ref-type="bibr">16</xref>,<xref rid="B17-pharmaceutics-14-00122" ref-type="bibr">17</xref>]. In the meantime, a single feature descriptor (i.e., AAC) and a single threshold value were implemented in the SCMTHP predictor, and it was found that the approach could easily distinguish THPs from non-THPs.</p>
      </list-item>
      <list-item>
        <p>Extensive benchmarking experiments show that SCMTHP could outperforms almost all ML-based predictors (e.g., decision tree (DT), k-nearest neighbor (KNN), multi-layer perceptron (MLP), naive Bayes (NB) and partial least squares regression (PLS)) as well as state-of-the-art THP predictors in terms of accuracy, cost-effectiveness and simplicity.</p>
      </list-item>
      <list-item>
        <p>In order to characterize tumor-homing activities of peptides, SCMTHP-derived propensity scores of 20 amino acids were employed to determine informative physicochemical properties (PCPs) of amino acids as provided in the AAIndex database [<xref rid="B18-pharmaceutics-14-00122" ref-type="bibr">18</xref>]. The importance of Cys residue in stabilization and the preference for high extinction coefficients are revealed by an analysis of SCMTHP-derived propensity scores.</p>
      </list-item>
      <list-item>
        <p>A user-friendly online web server was built and deployed publicly at <uri xlink:href="http://pmlabstack.pythonanywhere.com/SCMTHP">http://pmlabstack.pythonanywhere.com/SCMTHP</uri> (accessed on 27 December 2021) in order to facilitate online high-throughput THP identification. We believe that the SCMTHP predictor and SCMTHP-derived propensity scores will be helpful in facilitating THP identification as well as improving our understanding of their biophysical and biochemical properties.</p>
      </list-item>
    </list>
  </sec>
  <sec id="sec2-pharmaceutics-14-00122">
    <title>2. Materials and Methods</title>
    <sec id="sec2dot1-pharmaceutics-14-00122">
      <title>2.1. Dataset Preparation</title>
      <p>In order to conduct a fair test, the proposed method was optimized and evaluated using the same benchmark datasets (i.e., the Main and Small datasets) as performed in our previous work [<xref rid="B14-pharmaceutics-14-00122" ref-type="bibr">14</xref>]. Sharma et al. [<xref rid="B13-pharmaceutics-14-00122" ref-type="bibr">13</xref>] originally compiled these two benchmark datasets. Particularly, there are 1302 sequences in the Main dataset (651 THPs and 651 non-THPs) and 938 sequences in the Small dataset (469 THPs and 469 non-THPs). The THP samples in the Main dataset were obtained from the TumorHoPe [<xref rid="B19-pharmaceutics-14-00122" ref-type="bibr">19</xref>] database and were experimentally validated THPs whereas non-THP samples were obtained by randomly selecting peptides from SwissProt [<xref rid="B13-pharmaceutics-14-00122" ref-type="bibr">13</xref>]. Particularly, the Small dataset was created by taking a subset of the Main dataset and selecting peptides in the range of 4 and 10 residues. To test the model’s effectiveness, 161 THPs and 161 non-THPs were chosen at random from the set of 1302 sequences that will be referred to as the independent dataset (Main-IND) while the remaining sequences were used as the training dataset (Main-TRN) (490 THPs and 490 non-THPs). Similarly, 119 THPs and 119 non-THPs were chosen at random from the set of 938 sequences to form the independent dataset (Small-IND) while the remaining sequences formed the training dataset (Small-TRN) (350 THPs and 350 non-THPs). Note that the two benchmark datasets along with their training and independent datasets can be downloaded from <uri xlink:href="http://pmlabstack.pythonanywhere.com/dataset_SCMTHP">http://pmlabstack.pythonanywhere.com/dataset_SCMTHP</uri> (accessed on 27 December 2021).</p>
    </sec>
    <sec id="sec2dot2-pharmaceutics-14-00122">
      <title>2.2. Scoring Card Method</title>
      <p>SCM has been shown to afford good predictive performance as well as achieve comparable results to those of popular ML classifiers [<xref rid="B20-pharmaceutics-14-00122" ref-type="bibr">20</xref>,<xref rid="B21-pharmaceutics-14-00122" ref-type="bibr">21</xref>,<xref rid="B22-pharmaceutics-14-00122" ref-type="bibr">22</xref>,<xref rid="B23-pharmaceutics-14-00122" ref-type="bibr">23</xref>]. The contribution of the SCM method is summarized in the following three aspects. First, unlike complex methods such as SVM and RF, the SCM method can discriminate positive samples from negative samples using only the simple weighted-sum function. This emphasizes its ease-of-use and interpretability [<xref rid="B24-pharmaceutics-14-00122" ref-type="bibr">24</xref>,<xref rid="B25-pharmaceutics-14-00122" ref-type="bibr">25</xref>]. Second, as the SCM method is based on a single feature descriptor (i.e., AAC or DPC) and a threshold value, which suggests that this method could achieve better computational efficiency as compared to other conventional complex methods [<xref rid="B26-pharmaceutics-14-00122" ref-type="bibr">26</xref>,<xref rid="B27-pharmaceutics-14-00122" ref-type="bibr">27</xref>]. Third, the estimated propensity scores of 20 amino acids and 400 dipeptides enables an automatic identification of informative PCPs provided in the AAIndex database [<xref rid="B18-pharmaceutics-14-00122" ref-type="bibr">18</xref>] that might be useful for characterizing and analyzing various functions of proteins and peptides. Below is a detailed description on the estimation of SCM-derived propensity scores and construction of the SCMTHP model using the Main dataset.</p>
      <p>Phase 1: The training (Main-TRN) and independent (Main-IND) datasets are prepared. Particularly, the Main-TRN dataset was employed to determine the optimized propensity scores of 20 amino acids (Optimized-APS). Afterwards, the Optimized-APS was used to estimate the threshold value for the identification of unknown peptides as THPs or non-THPs.</p>
      <p>Phase 2: Computing the ratio between each amino acid by the occurrence frequency of aa(i) for THP and non-THP classes to generate the initial propensity scores of 20 amino acids (Initial-APS). Taking Cys as an example, the frequency of Cys in THP and non-THP classes was 650 and 200, respectively. The normalized Cys compositions in THP and non-THP classes were 0.6 and 0.2, respectively. Finally, we normalized the score of each amino acid to be in the range of 0–1000 in order to facilitate the feature analysis. Our previous studies provide more information on how Initial-APS are calculated [<xref rid="B15-pharmaceutics-14-00122" ref-type="bibr">15</xref>,<xref rid="B17-pharmaceutics-14-00122" ref-type="bibr">17</xref>].</p>
      <p>Phase 3: Genetic algorithm (GA) was used for optimizing the Initial-APS in order to maximize the predictive performance and to preserve the original information of THPs [<xref rid="B17-pharmaceutics-14-00122" ref-type="bibr">17</xref>,<xref rid="B28-pharmaceutics-14-00122" ref-type="bibr">28</xref>]. Particularly, the GA’s fitness function (<inline-formula><mml:math id="mm1" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Fit</mml:mi><mml:mfenced><mml:mrow><mml:mi>APS</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math></inline-formula>) was defined by the area under the receiver-operating curve (ROC) curve (AUC) value and the Pearson’s correlation coefficient (R value) between the Initial-APS and Optimized-APS.
<disp-formula id="FD1-pharmaceutics-14-00122"><label>(1)</label><mml:math id="mm2" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Fit</mml:mi><mml:mfenced><mml:mrow><mml:mi>APS</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="normal">W</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>×</mml:mo><mml:mi>AUC</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mrow><mml:mo> </mml:mo><mml:mi mathvariant="normal">W</mml:mi></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo>×</mml:mo><mml:mi mathvariant="normal">R</mml:mi></mml:mrow></mml:mrow></mml:math></disp-formula>
where <inline-formula><mml:math id="mm3" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">W</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.9</mml:mn></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="mm4" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">W</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.1</mml:mn></mml:mrow></mml:mrow></mml:math></inline-formula>. Weights for <inline-formula><mml:math id="mm5" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">W</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="mm6" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">W</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> were directly obtained from our previous studies [<xref rid="B16-pharmaceutics-14-00122" ref-type="bibr">16</xref>,<xref rid="B17-pharmaceutics-14-00122" ref-type="bibr">17</xref>]. Note that the <inline-formula><mml:math id="mm7" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Fit</mml:mi><mml:mfenced><mml:mrow><mml:mi>APS</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math></inline-formula> function was performed using a 10-fold cross-validation procedure in order to avoid the overfitting issue. A detailed description on the determination of Optimized-APS by means of the GA algorithm is provided in the Supplementary information.</p>
      <p>Phase 4: Constructing a scoring function <inline-formula><mml:math id="mm8" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>SF</mml:mi><mml:mfenced><mml:mi mathvariant="normal">P</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math></inline-formula> based on the Optimized-APS. The <inline-formula><mml:math id="mm9" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>SF</mml:mi><mml:mfenced><mml:mi mathvariant="normal">P</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math></inline-formula> function was used to calculate THP scores for query peptides P. The <inline-formula><mml:math id="mm10" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>SF</mml:mi><mml:mfenced><mml:mi mathvariant="normal">P</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math></inline-formula> function can be defined as follows:<disp-formula id="FD2-pharmaceutics-14-00122"><label>(2)</label><mml:math id="mm11" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>SF</mml:mi><mml:mfenced><mml:mi mathvariant="normal">P</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:munderover><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>20</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>aa</mml:mi></mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mi>APS</mml:mi></mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></disp-formula>
where <inline-formula><mml:math id="mm12" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:msub><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="mm13" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:msub><mml:mi mathvariant="normal">S</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> represent the occurrence frequency and propensity score of the ith amino acid.</p>
      <p>Phase 5: Identifying the biological function of a query peptide P and determining the optimal threshold value (<inline-formula><mml:math id="mm14" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Cutoff</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula>) yielding the highest cross-validation performance. For a given unknown peptide P, it is classified as THP if <inline-formula><mml:math id="mm15" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>SF</mml:mi><mml:mfenced><mml:mi mathvariant="normal">P</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math></inline-formula> is greater than the <inline-formula><mml:math id="mm16" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Cutoff</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> otherwise P is classified as non-THP.
<disp-formula id="FD3-pharmaceutics-14-00122"><label>(3)</label><mml:math id="mm17" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Pred</mml:mi><mml:mfenced><mml:mi mathvariant="normal">P</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="" open="{"><mml:mrow><mml:mtable equalrows="true" equalcolumns="true"><mml:mtr><mml:mtd><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mstyle displaystyle="true"><mml:munderover><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>20</mml:mn></mml:mrow></mml:munderover></mml:mstyle><mml:msub><mml:mrow><mml:mi>aa</mml:mi></mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mi>APS</mml:mi></mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:mo>&gt;</mml:mo><mml:mi>Cutoff</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mstyle displaystyle="true"><mml:munderover><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>20</mml:mn></mml:mrow></mml:munderover></mml:mstyle><mml:msub><mml:mrow><mml:mi>aa</mml:mi></mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mi>APS</mml:mi></mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:mo>&lt;</mml:mo><mml:mi>Cutoff</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math></disp-formula>
where <inline-formula><mml:math id="mm18" overflow="scroll"><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="mm19" overflow="scroll"><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula> represent THP and non-THP classes, respectively. For the Small dataset, its propensity scores can be calculated in the same process without significant modifications.</p>
    </sec>
    <sec id="sec2dot3-pharmaceutics-14-00122">
      <title>2.3. Characterization of THPs Using Informative Physicochemical Properties</title>
      <p>To characterize the tumor-homing activities of peptides, the propensity scores of 20 amino acids were used to identify the important PCPs from the AAindex database [<xref rid="B18-pharmaceutics-14-00122" ref-type="bibr">18</xref>]. The following steps were used to determine the set of informative PCPs using SCMTHP: (i) PCPs with the value ‘NA’ were not included in this study. As for the remaining 531 PCPs, we computed R values for propensity scores of 20 amino acids and each of the 531 PCPs, and (ii) if the R values were &gt;0.5, these PCPs were considered as candidate PCPs for THPs analysis. Note that PCPs with the highest R values were deemed to be the most important.</p>
    </sec>
    <sec id="sec2dot4-pharmaceutics-14-00122">
      <title>2.4. Conventional ML-Based Classifiers </title>
      <p>SCMTHP was compared to ML-based classifiers trained with various ML algorithms (DT, KNN, MLP, NB, PLS and SVM) and sequence-based feature descriptors (AAC, DPC, PCP, amino acid index (AAI) and composition-transition-distribution (CTD)). In addition, linear (namely, SVMLN) and radial basis function (namely, SVMRBF) kernels were utilized for constructing SVM-based classifiers. The five different sequence-based feature descriptors were extracted using the iFeature module in the Python environment [<xref rid="B20-pharmaceutics-14-00122" ref-type="bibr">20</xref>]. The Scikit-learn package in Python (version 0.22) was then used to generate ML classifiers for each feature descriptor individually [<xref rid="B29-pharmaceutics-14-00122" ref-type="bibr">29</xref>]. The optimal parameters of MLP-based, SVMLN-based and SVMRBF-based classifiers were determined using a 10-fold cross-validation procedure on the training (Main-TRN and Small-TRN) datasets, where the search range is shown in <xref rid="app1-pharmaceutics-14-00122" ref-type="app">Supplementary Table S1</xref>. In the meantime, the remaining ML-based classifiers were implemented with their default parameters. Using the Scikit-learn package in Python (version 0.22) [<xref rid="B29-pharmaceutics-14-00122" ref-type="bibr">29</xref>], 35 ML-based classifiers (7 MLs × 5 descriptors) were created in this study.</p>
    </sec>
    <sec id="sec2dot5-pharmaceutics-14-00122">
      <title>2.5. Performance Evaluation</title>
      <p>Five common performance measures consisting of ACC, Sn, MCC, AUC and specificity (Sp) [<xref rid="B30-pharmaceutics-14-00122" ref-type="bibr">30</xref>,<xref rid="B31-pharmaceutics-14-00122" ref-type="bibr">31</xref>] were used to evaluate the predictive performance of our proposed model, the compared ML-based THP classifiers and the state-of-the-art method. These performance measures are defined as follows:<disp-formula id="FD4-pharmaceutics-14-00122"><label>(4)</label><mml:math id="mm20" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>ACC</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>TP</mml:mi><mml:mo>+</mml:mo><mml:mi>TN</mml:mi></mml:mrow><mml:mrow><mml:mfenced><mml:mrow><mml:mi>TP</mml:mi><mml:mo>+</mml:mo><mml:mi>TN</mml:mi><mml:mo>+</mml:mo><mml:mi>FP</mml:mi><mml:mo>+</mml:mo><mml:mi>FN</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="FD5-pharmaceutics-14-00122"><label>(5)</label><mml:math id="mm21" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Sn</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>TP</mml:mi></mml:mrow><mml:mrow><mml:mfenced><mml:mrow><mml:mi>TP</mml:mi><mml:mo>+</mml:mo><mml:mi>FN</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="FD6-pharmaceutics-14-00122"><label>(6)</label><mml:math id="mm22" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Sp</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>TN</mml:mi></mml:mrow><mml:mrow><mml:mfenced><mml:mrow><mml:mi>TN</mml:mi><mml:mo>+</mml:mo><mml:mi>FP</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="FD7-pharmaceutics-14-00122"><label>(7)</label><mml:math id="mm23" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>MCC</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>TP</mml:mi><mml:mo>×</mml:mo><mml:mi>TN</mml:mi><mml:mo>−</mml:mo><mml:mi>FP</mml:mi><mml:mo>×</mml:mo><mml:mi>FN</mml:mi></mml:mrow><mml:mrow><mml:msqrt><mml:mrow><mml:mfenced><mml:mrow><mml:mi>TP</mml:mi><mml:mo>+</mml:mo><mml:mi>FP</mml:mi></mml:mrow></mml:mfenced><mml:mfenced><mml:mrow><mml:mi>TP</mml:mi><mml:mo>+</mml:mo><mml:mi>FN</mml:mi></mml:mrow></mml:mfenced><mml:mfenced><mml:mrow><mml:mi>TN</mml:mi><mml:mo>+</mml:mo><mml:mi>FP</mml:mi></mml:mrow></mml:mfenced><mml:mfenced><mml:mrow><mml:mi>TN</mml:mi><mml:mo>+</mml:mo><mml:mi>FN</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:msqrt></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:math></disp-formula>
where TP, TN, FP and FN represent the number of true positives, true negatives, false positive and false negatives, respectively [<xref rid="B32-pharmaceutics-14-00122" ref-type="bibr">32</xref>,<xref rid="B33-pharmaceutics-14-00122" ref-type="bibr">33</xref>,<xref rid="B34-pharmaceutics-14-00122" ref-type="bibr">34</xref>].</p>
    </sec>
  </sec>
  <sec sec-type="results" id="sec3-pharmaceutics-14-00122">
    <title>3. Results and Discussion</title>
    <sec id="sec3dot1-pharmaceutics-14-00122">
      <title>3.1. Performance of Different Propensity Scores</title>
      <p>In this section, we used 10-fold cross-validation and independent tests to investigate and evaluate the performance of variant SCM models trained using different sets of Optimized-APS on the two benchmark datasets (i.e., the Main and Small datasets). In this study, ten independent runs were performed for each of the two benchmark datasets to generate ten different sets of Optimized-APS using the GA algorithm, which were then used to construct ten different SCM models. <xref rid="app1-pharmaceutics-14-00122" ref-type="app">Supplementary Tables S2–S5</xref> summarize the cross-validation and independent test results, respectively.</p>
      <p>As can be seen from the <xref rid="app1-pharmaceutics-14-00122" ref-type="app">Supplementary Table S2</xref>, the 10th experiment achieved the highest ACC of 0.820 with an MCC of 0.641 and an AUC of 0.869. Furthermore, the 7th and 2nd experiments achieved the second and third highest prediction results, respectively. Interestingly, the 10th experiment also provided the best independent test result in terms of all performance metrics on the Main-IND dataset. To be specific, the ACC, MCC and AUC from the 10th experiment had values of 0.827, 0.656 and 0.869, respectively (<xref rid="app1-pharmaceutics-14-00122" ref-type="app">Supplementary Table S3</xref>). In case of the Small dataset, the 3rd and 7th experiments were found to achieve superior performance when compared with other experiments as evaluated on the Small-TRN dataset (<xref rid="app1-pharmaceutics-14-00122" ref-type="app">Supplementary Table S4</xref>). Notably, the 3rd experiment could achieve the best independent test result as indicated by three out of five performance metrics (ACC, Sp and MCC) on the Small-IND dataset. Particularly, the ACC, Sp and MCC from the 3rd experiment had corresponding values of 0.798, 0.830 and 0.597, respectively (<xref rid="app1-pharmaceutics-14-00122" ref-type="app">Supplementary Table S5</xref>). Altogether, SCM models were constructed using the Optimized-APS from the 10th and 3rd experiments (<xref rid="pharmaceutics-14-00122-f002" ref-type="fig">Figure 2</xref>), respectively, for the Main and Small datasets that is referred herein as SCMTHP. In addition, these two sets of Optimized-APS will be employed for further analysis.</p>
    </sec>
    <sec id="sec3dot2-pharmaceutics-14-00122">
      <title>3.2. Comparison of SCMTHP with Well-Known ML Classifiers and Existing Methods</title>
      <p>In this section, we compared the predictive performance of SCMTHP with conventional ML classifiers as well as state-of-the-art method. To ensure fairness and objectivity, all of the compared ML-based classifiers and state-of-the-art method were developed and evaluated using the same training (i.e., the Main-TRN and Small-TRN) and independent (i.e., the Main-IND and Small-IND) datasets as presented in THPep [<xref rid="B14-pharmaceutics-14-00122" ref-type="bibr">14</xref>]. Particularly, there are two existing methods that had been developed for THP identification (TumorHPD [<xref rid="B13-pharmaceutics-14-00122" ref-type="bibr">13</xref>] and THPep [<xref rid="B14-pharmaceutics-14-00122" ref-type="bibr">14</xref>]). However, THPep is the only existing method that was developed and evaluated based on the above-mentioned benchmark datasets. Therefore, the performance of SCMTHP was compared with THPep only. Results from comparing SCMTHP with conventional ML classifiers and state-of-the-art method are shown in <xref rid="pharmaceutics-14-00122-f003" ref-type="fig">Figure 3</xref>, <xref rid="pharmaceutics-14-00122-t001" ref-type="table">Table 1</xref> as well as <xref rid="app1-pharmaceutics-14-00122" ref-type="app">Supplementary Figure S1</xref> and <xref rid="app1-pharmaceutics-14-00122" ref-type="app">Tables S6–S9</xref>.</p>
      <p><xref rid="pharmaceutics-14-00122-f003" ref-type="fig">Figure 3</xref> and <xref rid="app1-pharmaceutics-14-00122" ref-type="app">Supplementary Figure S1</xref> revealed several observations as follows. First, among the seven ML-based classifiers that are compared, the SVMRBF-based classifier was found to achieve the best mean ACC of 0.804 and 0.775 as evaluated on the Main-TRN and Small-TRN datasets, respectively, while SVMLN-based (0.780, 0.763) and MLP-based (0.788, 0.756) classifiers achieved a similar level of performance and could perform well with the second highest performance. Second, it could be observed that SVMRBF-AAC and SCMTHP could achieve the best cross-validation performance (ACC, MCC) of (0.833, 0.669) and (0.808, 0.628) on the Main-TRN and Small-TRN datasets, respectively. For the Main-TRN dataset, SCMTHP produced ACC and MCC of 0.820 and 0.641, respectively, which was very comparable to that of SVMRBF-AAC. Third, the SCM-based classifier was found to outperform DT-based, KNN-based, MLP-based, NB-based, PLS-based and SVMLN-based classifiers on both the Main-TRN and Small-TRN datasets. Fourth, independent test results indicated similar results to that observed from the cross-validation test. Particularly, SCMTHP achieved ACC of 0.827 and 0.798 on Main-IND and Small-IND datasets, respectively, which outperformed several ML-based classifiers as developed in this study with the exception of SVMRBF-CTD.</p>
      <p>We also put the SCMTHP to the test and compared it to THPep. The ACC of SCMTHP as evaluated on Main-IND and Small-IND datasets provided corresponding values of 0.827 and 0.798, respectively, which were comparable to that of THPred (0.846 and 0.798, respectively) (<xref rid="pharmaceutics-14-00122-t001" ref-type="table">Table 1</xref>). It was recognized that THPred was created by combining the complex ensemble method (i.e., the RF algorithm) with AAC and PAAC [<xref rid="B14-pharmaceutics-14-00122" ref-type="bibr">14</xref>]. On the other hand, SCMTHP was trained using a simple weighted-sum classifier (<inline-formula><mml:math id="mm24" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>SF</mml:mi><mml:mfenced><mml:mi mathvariant="normal">P</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math></inline-formula>) and a single feature descriptor (i.e., AAC). Such model could provide us with the propensity scores of 20 amino acids to be THPs in an easily interpretable manner from a biologist’s perspective. In terms of accuracy, cost-effectiveness and simplicity, the proposed SCMTHP could outperform the compared ML-based classifiers and the state-of-the-art method.</p>
    </sec>
    <sec id="sec3dot3-pharmaceutics-14-00122">
      <title>3.3. Contribution of Optimized Propensity Scores </title>
      <p>As previously stated, the SCM approach was used to generate and optimize propensity scores of 20 amino acids in governing its contribution of becoming THPs in order to maximize their predictive ability and interpretability. The performance of the Optimized-APS was compared to the Initial-APS using 10-fold cross-validation and independent tests on the Main and Small datasets. <xref rid="app1-pharmaceutics-14-00122" ref-type="app">Supplementary Table S10</xref> shows the detailed performance of the Optimized-APS and the Initial-APS. Note that the Optimized-APS demonstrated the best overall predictive performance across the board in terms of all five performance metrics. On the Main-TRN and Main-IND datasets, the Optimized-APS had maximum cross-validation and independent test MCC of 0.641 and 0.626, respectively, which are correspondingly 13% and 17.6% higher than the Initial-APS (0.511 and 0.480, respectively). Interestingly, the Optimized-APS could outperform the Initial-APS in four out of five performance metrics as evaluated on the Small-TRN and Small-IND datasets (i.e., ACC, Sp, MCC and AUC). Remarkably, the ACC, Sp, MCC and AUC for Optimized-APS had values of 6.9%, 17.0%, 13.5% and 1.3%, respectively, which was higher than that of the Initial-APS. Moreover, as can be seen from <xref rid="pharmaceutics-14-00122-f004" ref-type="fig">Figure 4</xref>, Optimized-APS exhibited more discriminative ability in classifying THPs from non-THPs than that of Initial-APS as evaluated on the Main (<xref rid="pharmaceutics-14-00122-f004" ref-type="fig">Figure 4</xref>A,B) and Small datasets (<xref rid="pharmaceutics-14-00122-f004" ref-type="fig">Figure 4</xref>C,D). The aforementioned results confirmed that the proposed Optimized-APS (i.e., propensity scores of 20 amino acids or SCMTHP-derived propensity scores) was effective at discriminating THPs from non-THPs.</p>
    </sec>
    <sec id="sec3dot4-pharmaceutics-14-00122">
      <title>3.4. Identification of Potential THPs Using SCMTHP-Derived Propensity Scores</title>
      <p>This section explores the use of SCMTHP for measuring the tumor homing ability of peptides using THP score calculated from a simple weighted-sum function (S(P)). This weighted-sum function was generated using the propensity scores of 20 amino acids from the 10th experiment where the threshold value is set to 301 (<xref rid="app1-pharmaceutics-14-00122" ref-type="app">Supplementary Table S2</xref>). It should be noted that peptide sequences with the highest THP scores could be considered as high-potential THPs. As can be seen from <xref rid="pharmaceutics-14-00122-t002" ref-type="table">Table 2</xref> and <xref rid="pharmaceutics-14-00122-t003" ref-type="table">Table 3</xref>, several observations can be summarized as follows. First, mean, maximum and minimum THP scores for the top 20 THPs had corresponding values of 610.25, 684 and 571, respectively, while the mean, maximum and minimum scores of the top 20 non-THPs were 149, 1490 and 0, respectively. Second, the top-five high-potential THPs consisted of CFWPNRC (684), QWCSRRWCT (657), WTCRASWCS (632), SGWCYRC (631) and RWCREKSCW (631) that correspondingly had THP scores larger than 630. Third, note that almost all top 20 high-potential THPs would consist of at least two Cys residue with the exception of two peptides (i.e., WRPCES and WREWFL). Interesting, the top 20 non-THPs did not contain Cys residue in their primary sequences. Thus, we suggest that Cys residue and disulfide bonds may be important for THPs.</p>
    </sec>
    <sec id="sec3dot5-pharmaceutics-14-00122">
      <title>3.5. Characterization of THPs Using SCMTHP-Derived Propensity Scores</title>
      <p>It is well recognized that THPs are beneficial for cancer therapy [<xref rid="B1-pharmaceutics-14-00122" ref-type="bibr">1</xref>]. Insights from previous studies revealed that THPs had a typical length between 3 and 15 residues. Coincidentally, this has been reported to specifically recognize and bind tumor cells or tumor vasculature such as RGD peptides (bind to <inline-formula><mml:math id="mm25" overflow="scroll"><mml:mrow><mml:mi mathvariant="sans-serif">α</mml:mi></mml:mrow></mml:math></inline-formula><sub>v</sub> integrins) and NGR peptides (bind to a receptor aminopeptidase N) [<xref rid="B35-pharmaceutics-14-00122" ref-type="bibr">35</xref>,<xref rid="B36-pharmaceutics-14-00122" ref-type="bibr">36</xref>]. Until now, many studies have attempted to identify and analyze THPs in terms of their selection and specification to different types of cancers. Herein, we proposed SCMTHP that was able to not only make predictions but also estimate the propensity scores of 20 amino acids in their contribution to THPs along with interpretation of their biological significance [<xref rid="B15-pharmaceutics-14-00122" ref-type="bibr">15</xref>,<xref rid="B16-pharmaceutics-14-00122" ref-type="bibr">16</xref>,<xref rid="B17-pharmaceutics-14-00122" ref-type="bibr">17</xref>]. <xref rid="pharmaceutics-14-00122-f002" ref-type="fig">Figure 2</xref> shows the propensity scores of 20 amino acids to be THPs as obtained from SCMTHP using Main-TRN (<xref rid="pharmaceutics-14-00122-f002" ref-type="fig">Figure 2</xref>A) and Small-TRN (<xref rid="pharmaceutics-14-00122-f002" ref-type="fig">Figure 2</xref>B) datasets. As already mentioned above, the propensity scores of 20 amino acids were obtained from Optimized-APS particularly from the 10th and 3rd experiments as evaluated on Main-TRN and Small-TRN, respectively. Note that amino acids exhibiting the highest propensity scores are also deemed to be the most important for tumor homing activity of peptides. In addition, <xref rid="pharmaceutics-14-00122-t004" ref-type="table">Table 4</xref> summarizes propensity scores of 20 amino acids to be THPs with corresponding amino acid compositions (%) of THP and non-THPs using the Main-TRN dataset. </p>
      <p>Several observations can be made from <xref rid="pharmaceutics-14-00122-t004" ref-type="table">Table 4</xref> as follows. (i) The five top-ranking amino acids having highest propensities for THPs included Cys, Trp, Arg, Pro and Phe with corresponding scores of 1000, 981, 598, 587 and 424, respectively, while five top-ranking amino acids with the lowest propensities for THPs were Ile, Lys, Val, Glu and Asp with corresponding scores of 0, 45, 48, 67 and 103, respectively. (ii) Cys, Trp, Arg and Pro with corresponding scores of 8.552, 2.371, 3.885 and 1.891, respectively, were the four top-ranking amino acids that correspondingly had the highest percentage difference of the composition. Meanwhile Ile, Lys, Val, Glu and Asp with corresponding scores of −3.066, −2.540, −2.514, −2.609 and −1.866, respectively, were the five top-ranking amino acids correspondingly having the lowest percentage difference of the composition. (iii) All of the four top-ranking amino acids having the highest and lowest propensities were significantly different with <italic toggle="yes">p</italic> &lt; 0.01; they also had the largest correlation coefficient values between the propensity scores of 20 amino acids (PS-THP) and difference scores with values exceeding 0.8.</p>
      <p>The aforementioned observation also confirmed the robustness of the SCMTHP-derived propensity scores of 20 amino acids for discriminating THPs from non-THPs. Such a result is consistent with computational analysis reported by several previous studies [<xref rid="B13-pharmaceutics-14-00122" ref-type="bibr">13</xref>,<xref rid="B14-pharmaceutics-14-00122" ref-type="bibr">14</xref>]. For example, Sharma et al. [<xref rid="B13-pharmaceutics-14-00122" ref-type="bibr">13</xref>] reported that Cys, Arg, Gly, Trp, Pro, Leu and Ser are more abundant in THPs. Meanwhile, Shoombuatong et al. [<xref rid="B14-pharmaceutics-14-00122" ref-type="bibr">14</xref>] showed that the three top-ranking informative amino acids were Cys, Trp and Arg, with corresponding mean decrease of the Gini index (MDGI) values of 139.48, 46.56 and 45.40, respectively. In the case of informative dipeptides, RC, GR, CR and CG were considered to be amongst the top four informative dipeptides [<xref rid="B14-pharmaceutics-14-00122" ref-type="bibr">14</xref>]. Note that Cys might be beneficial for the tumor-homing activity of peptides. In 1997, Pasqualini et al. [<xref rid="B37-pharmaceutics-14-00122" ref-type="bibr">37</xref>] showed that cyclic peptides having two disulfide bonds, such as the peptide sequence of CDCRGDCFC, could effectively bind to different integrins.</p>
      <p>As shown in <xref rid="pharmaceutics-14-00122-t002" ref-type="table">Table 2</xref>, the peptide sequence of CDCRGDCFC was found to be amongst the top 20 high-potential THPs that had a corresponding THP score of 598. The bicyclic CDCRGDCFC (RGD-4C) peptide is a ligand of integrins that can selectively bind αvβ3 and αvβ5 integrins, which are highly overexpressed on invading tumor endothelial cells and tumor vasculature [<xref rid="B38-pharmaceutics-14-00122" ref-type="bibr">38</xref>]. Bicyclic forms of the peptide RGD-4C afforded less affinity for αvβ3 integrin and significantly less water solubility than the cyclic-(N-Me-VRGDf) (Cilengitide), which is a similar target of αvβ3 integrin [<xref rid="B39-pharmaceutics-14-00122" ref-type="bibr">39</xref>]. Colombo et al. [<xref rid="B40-pharmaceutics-14-00122" ref-type="bibr">40</xref>] compared the anticancer activity between cyclic (CNGRC-TNF) and linear (GNGRG-TNF) peptides containing the Asn-Gly-Arg (NGR) motif. Their results showed that the disulfide-bridge of the cyclic peptide afforded &gt; 10 fold higher anti-tumor activity than that of the linear peptide. In addition, this group explored the dynamic behavior and conformational characteristics of NGR peptides with or without cyclic constraints by performing molecular dynamic (MD) simulations of two CNGRC peptides with and without disulfide bridges. Their analysis revealed that the disulfide bridge formation played a crucial role in the stabilization of the CNGRC peptide and enhancing the tumor targeting efficiency. Moreover, the insertion of a free Cys residue in investigated peptides could extend their half-life and binding affinities in tumors as reported by Pang et al. [<xref rid="B41-pharmaceutics-14-00122" ref-type="bibr">41</xref>]. Particularly, they added a free Cys residue in the cyclic internalizing RGD (iRGD) tumor-targeting peptide (CRGDK/RGPD/EC), which led to longer half-life and more accumulation in tumors.</p>
    </sec>
    <sec id="sec3dot6-pharmaceutics-14-00122">
      <title>3.6. Characterization of THPs Using Informative PCPs</title>
      <p>Several studies had reported that molecular weight [<xref rid="B17-pharmaceutics-14-00122" ref-type="bibr">17</xref>], side chain [<xref rid="B42-pharmaceutics-14-00122" ref-type="bibr">42</xref>,<xref rid="B43-pharmaceutics-14-00122" ref-type="bibr">43</xref>], solubility [<xref rid="B17-pharmaceutics-14-00122" ref-type="bibr">17</xref>], side chain [<xref rid="B42-pharmaceutics-14-00122" ref-type="bibr">42</xref>,<xref rid="B43-pharmaceutics-14-00122" ref-type="bibr">43</xref>] and beta-sheet propensity [<xref rid="B44-pharmaceutics-14-00122" ref-type="bibr">44</xref>] were important factors for providing better understanding on functional mechanisms of proteins and peptides [<xref rid="B16-pharmaceutics-14-00122" ref-type="bibr">16</xref>,<xref rid="B21-pharmaceutics-14-00122" ref-type="bibr">21</xref>,<xref rid="B24-pharmaceutics-14-00122" ref-type="bibr">24</xref>]. To be specific, from among several of these biochemical and biophysical properties, pI, hydrophobicity, side bulk, hydrophobicity, hydrophilicity and molecular weight have been reported to affect biological activities of peptides [<xref rid="B13-pharmaceutics-14-00122" ref-type="bibr">13</xref>,<xref rid="B45-pharmaceutics-14-00122" ref-type="bibr">45</xref>,<xref rid="B46-pharmaceutics-14-00122" ref-type="bibr">46</xref>,<xref rid="B47-pharmaceutics-14-00122" ref-type="bibr">47</xref>]. In this section, SCMTHP was applied for determining informative features from amongst the entire set of 531 PCPs in order to elucidate the relationship between THP scores and biochemical and biophysical properties. The set of 20 top-ranking informative PCPs having the largest R values are provided in <xref rid="app1-pharmaceutics-14-00122" ref-type="app">Supplementary Table S11</xref>. Moreover, it could be noticed that the five top-ranking PCPs having the largest R values consisted of MCMT640101, ZASB820101, RACS820104, GARJ730101 and WIMW960101 with corresponding R values of 0.635, 0.623, 0.557, 0.512 and 0.507, respectively.</p>
      <p>From among the five top-ranking PCPs with the largest R values, it was observed that the MCMT640101 property, described as the “Refractivity” [<xref rid="B48-pharmaceutics-14-00122" ref-type="bibr">48</xref>], had the highest positive R value of 0.635. This can be attributed to two important factors (i.e., amino acid compositions and the refraction values of the amino acid residues) that affects the refractive indices. The high positive R value demonstrated that the refractivity property might be important for the functional mechanisms of THPs. McMeekin et al. described that the molar refraction property of amino acids can be measured by their aqueous solutions and via the Lorenz-Lorentz’s equation [<xref rid="B48-pharmaceutics-14-00122" ref-type="bibr">48</xref>]. Their analysis showed that the refractive index is a unique characteristic of a protein that depends on the extinction coefficient (imaginary index) [<xref rid="B49-pharmaceutics-14-00122" ref-type="bibr">49</xref>,<xref rid="B50-pharmaceutics-14-00122" ref-type="bibr">50</xref>]. As can be observed from <xref rid="pharmaceutics-14-00122-t005" ref-type="table">Table 5</xref>, the ranks of propensity scores (THP, refractivity, extinction coefficient) for Cys, Trp, Arg and Phe are (1, 2, 6), (2, 1, 1), (3, 5, 9) and (5, 4, 3), respectively. Furthermore, Kuipers and Gruppen reported that Trp exhibited the highest molar extinction coefficient of 29,050 while the second and third amino acids having the highest molar extinction coefficients were Tyr and Phe with respective extinction coefficients of 5375 and 5200, respectively. Note that the extinction coefficients of THPs might be higher than that of non-THPs. From <xref rid="pharmaceutics-14-00122-t002" ref-type="table">Table 2</xref> and <xref rid="pharmaceutics-14-00122-t003" ref-type="table">Table 3</xref>, the mean, maximum and minimum scores extinction coefficients for the set of 20 top-ranked high-potential THPs are 6117.25, 12,615 and 125, respectively, while the mean, maximum and minimum extinction coefficients of the set of top 20 non-THPs are 149, 1490 and 0, respectively. In addition, note that the extinction coefficients for almost all of the 20 top-ranked high-potential THPs exceeded 149 with the exception of four peptides (i.e., CPRGSRC, CPHSKPCLC, CSRPRRSEC and CSRPRRSVC). In the same way, 18 out of 20 from the set of top 20 non-THPs exhibited extinction coefficients of 0. We also employed Student’s <italic toggle="yes">t</italic>-test to compare extinction coefficients of THPs and non-THPs on the Main-TRN dataset. It was found that the extinction coefficient was significant for the differentiation of THPs from non-THPs at the level of <italic toggle="yes">p</italic> &lt; 0.001. These results indicated that the extinction coefficients of 20 amino acids were one of the important biochemical and biophysical properties governing THPs. As can be seen from <xref rid="pharmaceutics-14-00122-t005" ref-type="table">Table 5</xref>, it can be noticed that aromatic amino acids (i.e., Phe, Tyr and His) presented π electron that can absorb UV light. It could be stated that peptides having high refractivity may have an accumulation of peptides in tumor cells and their environment. Moreover, the isoelectric point obtained from peptides with the highest THP score was mild acid/base, whereas the remaining was strong acid/base. However, peptides with the highest THP score also contained mostly neutral and positive net charge but the remaining contained negative net charge. From the above mentioned results, it can be deduced that cationic THPs may behave as cell penetrating and cytolytic peptides [<xref rid="B51-pharmaceutics-14-00122" ref-type="bibr">51</xref>,<xref rid="B52-pharmaceutics-14-00122" ref-type="bibr">52</xref>].</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec4-pharmaceutics-14-00122">
    <title>4. Conclusions</title>
    <p>This study introduces SCMTHP as a novel, simple and interpretable scoring card (SCM)-based approach for in silico identification and characterization of THPs. The major contribution of the SCMTHP approach is the use of weighted-sum classifier as well as the new and improved propensity scores of 20 amino acids as THPs. Particularly, these propensity scores of 20 amino acids were used for identifying informative physicochemical properties that provided insights on characteristics of THPs. We have shown that SCMTHP could outperform almost all conventional ML-based predictors and state-of-the-art methods in terms of accuracy, conceptual simplicity and high interpretability in extensive comparative experiments on the two benchmark datasets. Furthermore, analysis revealed the significance of Cys residue in stabilization as well as a preference for high extinction coefficients. Finally, we have constructed a user-friendly online web server (<uri xlink:href="http://pmlabstack.pythonanywhere.com/SCMTHP">http://pmlabstack.pythonanywhere.com/SCMTHP</uri>) (accessed on 27 December 2021) to facilitate online high-throughput THP identification. The SCMTHP predictor and SCMTHP-derived propensity scores of 20 amino acids are expected to be useful tools for facilitating THP identification and for improving our understanding of their functional mechanisms.</p>
  </sec>
</body>
<back>
  <ack>
    <title>Acknowledgments</title>
    <p>This work was fully supported by College of Arts, Media and Technology, Chiang Mai University and partially supported by Chiang Mai University and Mahidol University. In addition, computational resources were supported by Information Technology Service Center (ITSC) of Chiang Mai University.</p>
  </ack>
  <fn-group>
    <fn>
      <p><bold>Publisher’s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <app-group>
    <app id="app1-pharmaceutics-14-00122">
      <title>Supplementary Materials</title>
      <p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/pharmaceutics14010122/s1">https://www.mdpi.com/article/10.3390/pharmaceutics14010122/s1</uri>, Figure S1: Performance evaluations of SCMTHP and other ML-based classifiers in terms of ACC and MCC as evaluated by 10-fold cross-validation (A,B) and independent (C,D) tests on the Small-TRN and Small-IND datasets, respectively; Table S1: Hyperparameter search details for seven popular ML algorithms; Table S2: Cross-validation of ten SCM models trained with ten different sets of propensity scores of amino acids on the Main-TRN dataset; Table S3: Independent test results of ten SCM models trained with ten different sets of propensity scores of amino acids on the Main-IND dataset, respectively; Table S4: Cross-validation of ten SCM models trained with ten different sets of propensity scores of amino acids on the Small-TRN dataset; Table S5: Independent test results of ten SCM models trained with ten different sets of propensity scores of amino acids on the Small-IND dataset, respectively; Table S6: Cross-validation results of seven different ML classifiers with five different feature encodings on Main-TRN dataset; Table S7: Independent test results of seven different ML classifiers with five different feature encodings on Main-IND dataset; Table S8: Cross-validation results of seven different ML classifiers with five different feature encodings on Small-TRN dataset; Table S9: Independent test results of seven different ML classifiers with five different feature encodings on Small-IND dataset; Table S10: Cross-validation and independent test results of SCM-based classifiers by using Initial-APS and Optimized-APS as evaluated on the Main and Small datasets; Table S11: The twenty top-ranked informative physicohemical properties having the highest pearson correlation (R) with the propensity scores of amino acids on Main-TRN dataset.</p>
      <supplementary-material id="pharmaceutics-14-00122-s001" position="float" content-type="local-data">
        <media xlink:href="pharmaceutics-14-00122-s001.zip">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </app>
  </app-group>
  <notes>
    <title>Author Contributions</title>
    <p>Conceptualization, methodology, validation, and visualization, W.S., B.M. and P.C.; project administration and supervision, W.S.; analysis and investigation, W.S. and W.C.; writing—original draft, M.A.M., P.L., W.S. and W.C.; web server development, P.C.; writing—review and editing, W.S. and C.N. All authors have read and agreed to the published version of the manuscript.</p>
  </notes>
  <notes>
    <title>Funding</title>
    <p>The National Research Foundation of Korea (NRF) funded by the Korean government (MSIT) (2021R1A2C1014338).</p>
  </notes>
  <notes>
    <title>Institutional Review Board Statement</title>
    <p>Not applicable.</p>
  </notes>
  <notes>
    <title>Informed Consent Statement</title>
    <p>Not applicable.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Data Availability Statement</title>
    <p>All the data are available at <uri xlink:href="http://pmlabstack.pythonanywhere.com/SCMTHP">http://pmlabstack.pythonanywhere.com/SCMTHP</uri> (accessed on 27 December 2021).</p>
  </notes>
  <notes notes-type="COI-statement">
    <title>Conflicts of Interest</title>
    <p>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.</p>
  </notes>
  <ref-list>
    <title>References</title>
    <ref id="B1-pharmaceutics-14-00122">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kondo</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Iioka</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Saito</surname>
            <given-names>K.</given-names>
          </name>
        </person-group>
        <article-title>Tumor-homing peptide and its utility for advanced cancer medicine</article-title>
        <source>Cancer Sci.</source>
        <year>2021</year>
        <volume>112</volume>
        <fpage>2118</fpage>
        <lpage>2125</lpage>
        <pub-id pub-id-type="pmid">33793015</pub-id>
      </element-citation>
    </ref>
    <ref id="B2-pharmaceutics-14-00122">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lingasamy</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Teesalu</surname>
            <given-names>T.</given-names>
          </name>
        </person-group>
        <article-title>Homing Peptides for Cancer Therapy</article-title>
        <source>Adv. Exp. Med. Biol.</source>
        <year>2021</year>
        <volume>1295</volume>
        <fpage>29</fpage>
        <lpage>48</lpage>
        <pub-id pub-id-type="pmid">33543454</pub-id>
      </element-citation>
    </ref>
    <ref id="B3-pharmaceutics-14-00122">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goyal</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Jerath</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Akhil</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Chandrasekharan</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Puppala</surname>
            <given-names>E.R.</given-names>
          </name>
          <name>
            <surname>Ponneganti</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Sarma</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Naidu</surname>
            <given-names>V.G.M.</given-names>
          </name>
          <name>
            <surname>Santhoshkumar</surname>
            <given-names>T.R.</given-names>
          </name>
          <name>
            <surname>Ramakrishnan</surname>
            <given-names>V.</given-names>
          </name>
        </person-group>
        <article-title>Geometry encoded functional programming of tumor homing peptides for targeted drug delivery</article-title>
        <source>J. Control. Release</source>
        <year>2021</year>
        <volume>333</volume>
        <fpage>16</fpage>
        <lpage>27</lpage>
        <pub-id pub-id-type="pmid">33722612</pub-id>
      </element-citation>
    </ref>
    <ref id="B4-pharmaceutics-14-00122">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Tao</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Fan</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A single nucleotide mutation drastically increases the expression of tumor-homing NGR-TNFalpha in the <italic toggle="yes">E. coli</italic> M15-pQE30 system by improving gene transcription</article-title>
        <source>Appl. Microbiol. Biotechnol.</source>
        <year>2021</year>
        <volume>105</volume>
        <fpage>1447</fpage>
        <lpage>1460</lpage>
        <pub-id pub-id-type="pmid">33528691</pub-id>
      </element-citation>
    </ref>
    <ref id="B5-pharmaceutics-14-00122">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ottaiano</surname>
            <given-names>T.F.</given-names>
          </name>
          <name>
            <surname>Andrade</surname>
            <given-names>S.S.</given-names>
          </name>
          <name>
            <surname>de Oliveira</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Silva</surname>
            <given-names>M.C.C.</given-names>
          </name>
          <name>
            <surname>Buri</surname>
            <given-names>M.V.</given-names>
          </name>
          <name>
            <surname>Juliano</surname>
            <given-names>M.A.</given-names>
          </name>
          <name>
            <surname>Girao</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Sampaio</surname>
            <given-names>M.U.</given-names>
          </name>
          <name>
            <surname>Schmaier</surname>
            <given-names>A.H.</given-names>
          </name>
          <name>
            <surname>Wlodawer</surname>
            <given-names>A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Plasma kallikrein enhances platelet aggregation response by subthreshold doses of ADP</article-title>
        <source>Biochimie</source>
        <year>2017</year>
        <volume>135</volume>
        <fpage>72</fpage>
        <lpage>81</lpage>
        <pub-id pub-id-type="pmid">28115185</pub-id>
      </element-citation>
    </ref>
    <ref id="B6-pharmaceutics-14-00122">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Donner</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Gremer</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Ziehm</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Gertzen</surname>
            <given-names>C.G.W.</given-names>
          </name>
          <name>
            <surname>Gohlke</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Willbold</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Elvers</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Relevance of N-terminal residues for amyloid-beta binding to platelet integrin alphaIIbbeta3, integrin outside-in signaling and amyloid-beta fibril formation</article-title>
        <source>Cell Signal.</source>
        <year>2018</year>
        <volume>50</volume>
        <fpage>121</fpage>
        <lpage>130</lpage>
        <pub-id pub-id-type="pmid">29964150</pub-id>
      </element-citation>
    </ref>
    <ref id="B7-pharmaceutics-14-00122">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kodandapani</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Veerapandian</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Kunicki</surname>
            <given-names>T.J.</given-names>
          </name>
          <name>
            <surname>Ely</surname>
            <given-names>K.R.</given-names>
          </name>
        </person-group>
        <article-title>Crystal structure of the OPG2 Fab. An antireceptor antibody that mimics an RGD cell adhesion site</article-title>
        <source>J. Biol. Chem.</source>
        <year>1995</year>
        <volume>270</volume>
        <fpage>2268</fpage>
        <lpage>2273</lpage>
        <pub-id pub-id-type="pmid">7836460</pub-id>
      </element-citation>
    </ref>
    <ref id="B8-pharmaceutics-14-00122">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kuo</surname>
            <given-names>Y.J.</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>C.H.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>T.F.</given-names>
          </name>
        </person-group>
        <article-title>From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent</article-title>
        <source>Toxins</source>
        <year>2019</year>
        <volume>11</volume>
        <fpage>372</fpage>
      </element-citation>
    </ref>
    <ref id="B9-pharmaceutics-14-00122">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gautam</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Kapoor</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Chaudhary</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Open Source Drug Discovery</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>G.P.</given-names>
          </name>
        </person-group>
        <article-title>Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics</article-title>
        <source>Curr. Med. Chem.</source>
        <year>2014</year>
        <volume>21</volume>
        <fpage>2367</fpage>
        <lpage>2391</lpage>
        <pub-id pub-id-type="pmid">24533809</pub-id>
      </element-citation>
    </ref>
    <ref id="B10-pharmaceutics-14-00122">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schug</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Sievert</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Urnauer</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Muller</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Schmohl</surname>
            <given-names>K.A.</given-names>
          </name>
          <name>
            <surname>Wechselberger</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Schwenk</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Lauber</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Schwaiger</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Multhoff</surname>
            <given-names>G.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>External Beam Radiation Therapy Enhances Mesenchymal Stem Cell-Mediated Sodium-Iodide Symporter Gene Delivery</article-title>
        <source>Hum. Gene Ther.</source>
        <year>2018</year>
        <volume>29</volume>
        <fpage>1287</fpage>
        <lpage>1300</lpage>
        <pub-id pub-id-type="pmid">29724129</pub-id>
      </element-citation>
    </ref>
    <ref id="B11-pharmaceutics-14-00122">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dutoit</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Migliorini</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Ranzanici</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Marinari</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Widmer</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Lobrinus</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Momjian</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Costello</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Walker</surname>
            <given-names>P.R.</given-names>
          </name>
          <name>
            <surname>Okada</surname>
            <given-names>H.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma</article-title>
        <source>Oncoimmunology</source>
        <year>2018</year>
        <volume>7</volume>
        <fpage>e1391972</fpage>
        <pub-id pub-id-type="pmid">29308320</pub-id>
      </element-citation>
    </ref>
    <ref id="B12-pharmaceutics-14-00122">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Migliorini</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Dutoit</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Allard</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Grandjean Hallez</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Marinari</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Widmer</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Philippin</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Corlazzoli</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Gustave</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Kreutzfeldt</surname>
            <given-names>M.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients</article-title>
        <source>Neuro. Oncol.</source>
        <year>2019</year>
        <volume>21</volume>
        <fpage>923</fpage>
        <lpage>933</lpage>
        <pub-id pub-id-type="pmid">30753611</pub-id>
      </element-citation>
    </ref>
    <ref id="B13-pharmaceutics-14-00122">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sharma</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Kapoor</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Gautam</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Chaudhary</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Chauhan</surname>
            <given-names>J.S.</given-names>
          </name>
          <name>
            <surname>Tyagi</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>G.P.</given-names>
          </name>
        </person-group>
        <article-title>Computational approach for designing tumor homing peptides</article-title>
        <source>Sci. Rep.</source>
        <year>2013</year>
        <volume>3</volume>
        <fpage>1607</fpage>
        <pub-id pub-id-type="pmid">23558316</pub-id>
      </element-citation>
    </ref>
    <ref id="B14-pharmaceutics-14-00122">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shoombuatong</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Schaduangrat</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Pratiwi</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Nantasenamat</surname>
            <given-names>C.</given-names>
          </name>
        </person-group>
        <article-title>THPep: A machine learning-based approach for predicting tumor homing peptides</article-title>
        <source>Comput. Biol. Chem.</source>
        <year>2019</year>
        <volume>80</volume>
        <fpage>441</fpage>
        <lpage>451</lpage>
        <pub-id pub-id-type="pmid">31151025</pub-id>
      </element-citation>
    </ref>
    <ref id="B15-pharmaceutics-14-00122">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Charoenkwan</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Chiangjong</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>V.S.</given-names>
          </name>
          <name>
            <surname>Nantasenamat</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Hasan</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>Shoombuatong</surname>
            <given-names>W.</given-names>
          </name>
        </person-group>
        <article-title>Improved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method</article-title>
        <source>Sci. Rep.</source>
        <year>2021</year>
        <volume>11</volume>
        <fpage>3017</fpage>
        <pub-id pub-id-type="pmid">33542286</pub-id>
      </element-citation>
    </ref>
    <ref id="B16-pharmaceutics-14-00122">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Charoenkwan</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Shoombuatong</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>H.-C.</given-names>
          </name>
          <name>
            <surname>Chaijaruwanich</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H.-L.</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>S.-Y.</given-names>
          </name>
        </person-group>
        <article-title>SCMCRYS: Predicting protein crystallization using an ensemble scoring card method with estimating propensity scores of P-collocated amino acid pairs</article-title>
        <source>PLoS ONE</source>
        <year>2013</year>
        <volume>8</volume>
        <elocation-id>e72368</elocation-id>
        <pub-id pub-id-type="pmid">24019868</pub-id>
      </element-citation>
    </ref>
    <ref id="B17-pharmaceutics-14-00122">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>H.-L.</given-names>
          </name>
          <name>
            <surname>Charoenkwan</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Kao</surname>
            <given-names>T.-F.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>H.-C.</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>F.-L.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>W.-L.</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>S.-J.</given-names>
          </name>
          <name>
            <surname>Shu</surname>
            <given-names>L.-S.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>W.-L.</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>S.-Y.</given-names>
          </name>
        </person-group>
        <article-title>Prediction and analysis of protein solubility using a novel scoring card method with dipeptide composition</article-title>
        <source>BMC Bioinform.</source>
        <year>2012</year>
        <volume>13</volume>
        <elocation-id>S3</elocation-id>
      </element-citation>
    </ref>
    <ref id="B18-pharmaceutics-14-00122">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kawashima</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Kanehisa</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>AAindex: Amino acid index database</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2000</year>
        <volume>28</volume>
        <fpage>374-374</fpage>
        <pub-id pub-id-type="pmid">10592278</pub-id>
      </element-citation>
    </ref>
    <ref id="B19-pharmaceutics-14-00122">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kapoor</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Gautam</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Chaudhary</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>G.P.</given-names>
          </name>
        </person-group>
        <article-title>TumorHoPe: A database of tumor homing peptides</article-title>
        <source>PLoS ONE</source>
        <year>2012</year>
        <volume>7</volume>
        <elocation-id>e35187</elocation-id>
        <pub-id pub-id-type="pmid">22523575</pub-id>
      </element-citation>
    </ref>
    <ref id="B20-pharmaceutics-14-00122">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Charoenkwan</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Kanthawong</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Nantasenamat</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Hasan</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>Shoombuatong</surname>
            <given-names>W.</given-names>
          </name>
        </person-group>
        <article-title>iAMY-SCM: Improved prediction and analysis of amyloid proteins using a scoring card method with propensity scores of dipeptides</article-title>
        <source>Genomics</source>
        <year>2021</year>
        <volume>113</volume>
        <fpage>689</fpage>
        <lpage>698</lpage>
        <pub-id pub-id-type="pmid">33017626</pub-id>
      </element-citation>
    </ref>
    <ref id="B21-pharmaceutics-14-00122">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Charoenkwan</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Kanthawong</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Nantasenamat</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Hasan</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>Shoombuatong</surname>
            <given-names>W.</given-names>
          </name>
        </person-group>
        <article-title>iDPPIV-SCM: A sequence-based predictor for identifying and analyzing dipeptidyl peptidase IV (DPP-IV) inhibitory peptides using a scoring card method</article-title>
        <source>J. Proteome Res.</source>
        <year>2020</year>
        <volume>19</volume>
        <fpage>4125</fpage>
        <lpage>4136</lpage>
        <pub-id pub-id-type="pmid">32897718</pub-id>
      </element-citation>
    </ref>
    <ref id="B22-pharmaceutics-14-00122">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vasylenko</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Liou</surname>
            <given-names>Y.-F.</given-names>
          </name>
          <name>
            <surname>Chiou</surname>
            <given-names>P.-C.</given-names>
          </name>
          <name>
            <surname>Chu</surname>
            <given-names>H.-W.</given-names>
          </name>
          <name>
            <surname>Lai</surname>
            <given-names>Y.-S.</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>Y.-L.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H.-L.</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>S.-Y.</given-names>
          </name>
        </person-group>
        <article-title>SCMBYK: Prediction and characterization of bacterial tyrosine-kinases based on propensity scores of dipeptides</article-title>
        <source>BMC Bioinform.</source>
        <year>2016</year>
        <volume>17</volume>
        <fpage>203</fpage>
        <lpage>217</lpage>
      </element-citation>
    </ref>
    <ref id="B23-pharmaceutics-14-00122">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liou</surname>
            <given-names>Y.-F.</given-names>
          </name>
          <name>
            <surname>Charoenkwan</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Srinivasulu</surname>
            <given-names>Y.S.</given-names>
          </name>
          <name>
            <surname>Vasylenko</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Lai</surname>
            <given-names>S.-C.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>H.-C.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y.-H.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H.-L.</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>S.-Y.</given-names>
          </name>
        </person-group>
        <article-title>SCMHBP: Prediction and analysis of heme binding proteins using propensity scores of dipeptides</article-title>
        <source>BMC Bioinform.</source>
        <year>2014</year>
        <volume>15</volume>
        <elocation-id>S4</elocation-id>
      </element-citation>
    </ref>
    <ref id="B24-pharmaceutics-14-00122">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Charoenkwan</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Yana</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Nantasenamat</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Hasan</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>Shoombuatong</surname>
            <given-names>W.</given-names>
          </name>
        </person-group>
        <article-title>iUmami-SCM: A novel sequence-based predictor for prediction and analysis of umami peptides using a scoring card method with propensity scores of dipeptides</article-title>
        <source>J. Chem. Inf. Modeling</source>
        <year>2020</year>
        <volume>60</volume>
        <fpage>6666</fpage>
        <lpage>6678</lpage>
      </element-citation>
    </ref>
    <ref id="B25-pharmaceutics-14-00122">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Charoenkwan</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Chotpatiwetchkul</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>V.S.</given-names>
          </name>
          <name>
            <surname>Nantasenamat</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Shoombuatong</surname>
            <given-names>W.</given-names>
          </name>
        </person-group>
        <article-title>A novel sequence-based predictor for identifying and characterizing thermophilic proteins using estimated propensity scores of dipeptides</article-title>
        <source>Sci. Rep.</source>
        <year>2021</year>
        <volume>11</volume>
        <fpage>23782</fpage>
        <pub-id pub-id-type="pmid">34893688</pub-id>
      </element-citation>
    </ref>
    <ref id="B26-pharmaceutics-14-00122">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liou</surname>
            <given-names>Y.-F.</given-names>
          </name>
          <name>
            <surname>Vasylenko</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Yeh</surname>
            <given-names>C.-L.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>W.-C.</given-names>
          </name>
          <name>
            <surname>Chiu</surname>
            <given-names>S.-H.</given-names>
          </name>
          <name>
            <surname>Charoenkwan</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Shu</surname>
            <given-names>L.-S.</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>S.-Y.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H.-L.</given-names>
          </name>
        </person-group>
        <article-title>SCMMTP: Identifying and characterizing membrane transport proteins using propensity scores of dipeptides</article-title>
        <source>BMC Genom.</source>
        <year>2015</year>
        <volume>16</volume>
        <elocation-id>S6</elocation-id>
      </element-citation>
    </ref>
    <ref id="B27-pharmaceutics-14-00122">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vasylenko</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Liou</surname>
            <given-names>Y.-F.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H.-A.</given-names>
          </name>
          <name>
            <surname>Charoenkwan</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H.-L.</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>S.-Y.</given-names>
          </name>
        </person-group>
        <article-title>SCMPSP: Prediction and characterization of photosynthetic proteins based on a scoring card method</article-title>
        <source>BMC Bioinform.</source>
        <year>2015</year>
        <volume>16</volume>
        <elocation-id>S8</elocation-id>
      </element-citation>
    </ref>
    <ref id="B28-pharmaceutics-14-00122">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Charoenkwan</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Schaduangrat</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Nantasenamat</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Piacham</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Shoombuatong</surname>
            <given-names>W.</given-names>
          </name>
        </person-group>
        <article-title>iQSP: A Sequence-Based Tool for the Prediction and Analysis of Quorum Sensing Peptides Using Informative Physicochemical Properties</article-title>
        <source>Int. J. Mol. Sci.</source>
        <year>2020</year>
        <volume>21</volume>
        <fpage>75</fpage>
      </element-citation>
    </ref>
    <ref id="B29-pharmaceutics-14-00122">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pedregosa</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Varoquaux</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Gramfort</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Michel</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Thirion</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Grisel</surname>
            <given-names>O.</given-names>
          </name>
          <name>
            <surname>Blondel</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Prettenhofer</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Weiss</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Dubourg</surname>
            <given-names>V.</given-names>
          </name>
        </person-group>
        <article-title>Scikit-learn: Machine learning in Python</article-title>
        <source>J. Mach. Learn. Res.</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>2825</fpage>
        <lpage>2830</lpage>
      </element-citation>
    </ref>
    <ref id="B30-pharmaceutics-14-00122">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Azadpour</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>McKay</surname>
            <given-names>C.M.</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>R.L.</given-names>
          </name>
        </person-group>
        <article-title>Estimating confidence intervals for information transfer analysis of confusion matrices</article-title>
        <source>J. Acoust. Soc. Am.</source>
        <year>2014</year>
        <volume>135</volume>
        <fpage>EL140</fpage>
        <lpage>EL146</lpage>
        <pub-id pub-id-type="pmid">24606307</pub-id>
      </element-citation>
    </ref>
    <ref id="B31-pharmaceutics-14-00122">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Charoenkwan</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Chiangjong</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Nantasenamat</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Hasan</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>Manavalan</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Shoombuatong</surname>
            <given-names>W.</given-names>
          </name>
        </person-group>
        <article-title>StackIL6: A stacking ensemble model for improving the prediction of IL-6 inducing peptides</article-title>
        <source>Brief. Bioinform.</source>
        <year>2021</year>
        <volume>22</volume>
        <fpage>bbab172</fpage>
        <pub-id pub-id-type="pmid">33963832</pub-id>
      </element-citation>
    </ref>
    <ref id="B32-pharmaceutics-14-00122">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Su</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Manavalan</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>L.</given-names>
          </name>
        </person-group>
        <article-title>Empirical comparison and analysis of web-based cell-penetrating peptide prediction tools</article-title>
        <source>Brief. Bioinform.</source>
        <year>2020</year>
        <volume>21</volume>
        <fpage>408</fpage>
        <lpage>420</lpage>
        <pub-id pub-id-type="pmid">30649170</pub-id>
      </element-citation>
    </ref>
    <ref id="B33-pharmaceutics-14-00122">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Basith</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Manavalan</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Hwan Shin</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>G.</given-names>
          </name>
        </person-group>
        <article-title>Machine intelligence in peptide therapeutics: A next-generation tool for rapid disease screening</article-title>
        <source>Med. Res. Rev.</source>
        <year>2020</year>
        <volume>40</volume>
        <fpage>1276</fpage>
        <lpage>1314</lpage>
        <pub-id pub-id-type="pmid">31922268</pub-id>
      </element-citation>
    </ref>
    <ref id="B34-pharmaceutics-14-00122">
      <label>34.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Shoombuatong</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Prathipati</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Owasirikul</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Worachartcheewan</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Simeon</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Anuwongcharoen</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Wikberg</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Nantasenamat</surname>
            <given-names>C.</given-names>
          </name>
        </person-group>
        <article-title>Towards the revival of interpretable QSAR models</article-title>
        <source>Advances in QSAR Modeling</source>
        <publisher-name>Springer</publisher-name>
        <publisher-loc>Berlin/Heidelberg, Germany</publisher-loc>
        <year>2017</year>
        <fpage>3</fpage>
        <lpage>55</lpage>
      </element-citation>
    </ref>
    <ref id="B35-pharmaceutics-14-00122">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zitzmann</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Ehemann</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Schwab</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo</article-title>
        <source>Cancer Res.</source>
        <year>2002</year>
        <volume>62</volume>
        <fpage>5139</fpage>
        <lpage>5143</lpage>
        <pub-id pub-id-type="pmid">12234975</pub-id>
      </element-citation>
    </ref>
    <ref id="B36-pharmaceutics-14-00122">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pasqualini</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Koivunen</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Kain</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Lahdenranta</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Sakamoto</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Stryhn</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Ashmun</surname>
            <given-names>R.A.</given-names>
          </name>
          <name>
            <surname>Shapiro</surname>
            <given-names>L.H.</given-names>
          </name>
          <name>
            <surname>Arap</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Ruoslahti</surname>
            <given-names>E.</given-names>
          </name>
        </person-group>
        <article-title>Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis</article-title>
        <source>Cancer Res.</source>
        <year>2000</year>
        <volume>60</volume>
        <fpage>722</fpage>
        <lpage>727</lpage>
        <pub-id pub-id-type="pmid">10676659</pub-id>
      </element-citation>
    </ref>
    <ref id="B37-pharmaceutics-14-00122">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pasqualini</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Koivunen</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Rouslahti</surname>
            <given-names>E.</given-names>
          </name>
        </person-group>
        <article-title>αv integrins as receptors for tumor targeting by circulating ligands</article-title>
        <source>Nat. Biotechnol.</source>
        <year>1997</year>
        <volume>15</volume>
        <fpage>542</fpage>
        <lpage>546</lpage>
        <pub-id pub-id-type="pmid">9181576</pub-id>
      </element-citation>
    </ref>
    <ref id="B38-pharmaceutics-14-00122">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>De Groot</surname>
            <given-names>F.M.</given-names>
          </name>
          <name>
            <surname>Broxterman</surname>
            <given-names>H.J.</given-names>
          </name>
          <name>
            <surname>Adams</surname>
            <given-names>H.P.</given-names>
          </name>
          <name>
            <surname>Van Vliet</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Tesser</surname>
            <given-names>G.I.</given-names>
          </name>
          <name>
            <surname>Elderkamp</surname>
            <given-names>Y.W.</given-names>
          </name>
          <name>
            <surname>Schraa</surname>
            <given-names>A.J.</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>R.J.</given-names>
          </name>
          <name>
            <surname>Molema</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Pinedo</surname>
            <given-names>H.M.</given-names>
          </name>
        </person-group>
        <article-title>Design, Synthesis, and Biological Evaluation of a Dual Tumor-specific Motive Containing Integrin-targeted Plasmin-cleavable Doxorubicin Prodrug 1 This work was partly supported by the Spinoza Award (to HMP). 1</article-title>
        <source>Mol. Cancer Ther.</source>
        <year>2002</year>
        <volume>1</volume>
        <fpage>901</fpage>
        <lpage>911</lpage>
        <pub-id pub-id-type="pmid">12481411</pub-id>
      </element-citation>
    </ref>
    <ref id="B39-pharmaceutics-14-00122">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Burkhart</surname>
            <given-names>D.J.</given-names>
          </name>
          <name>
            <surname>Kalet</surname>
            <given-names>B.T.</given-names>
          </name>
          <name>
            <surname>Coleman</surname>
            <given-names>M.P.</given-names>
          </name>
          <name>
            <surname>Post</surname>
            <given-names>G.C.</given-names>
          </name>
          <name>
            <surname>Koch</surname>
            <given-names>T.H.</given-names>
          </name>
        </person-group>
        <article-title>Doxorubicin-formaldehyde conjugates targeting αvβ3 integrin</article-title>
        <source>Mol. Cancer Ther.</source>
        <year>2004</year>
        <volume>3</volume>
        <fpage>1593</fpage>
        <lpage>1604</lpage>
        <pub-id pub-id-type="pmid">15634653</pub-id>
      </element-citation>
    </ref>
    <ref id="B40-pharmaceutics-14-00122">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Colombo</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Curnis</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>De Mori</surname>
            <given-names>G.M.</given-names>
          </name>
          <name>
            <surname>Gasparri</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Longoni</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Sacchi</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Longhi</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Corti</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif</article-title>
        <source>J. Biol. Chem.</source>
        <year>2002</year>
        <volume>277</volume>
        <fpage>47891</fpage>
        <lpage>47897</lpage>
        <pub-id pub-id-type="pmid">12372830</pub-id>
      </element-citation>
    </ref>
    <ref id="B41-pharmaceutics-14-00122">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pang</surname>
            <given-names>H.-B.</given-names>
          </name>
          <name>
            <surname>Braun</surname>
            <given-names>G.B.</given-names>
          </name>
          <name>
            <surname>She</surname>
            <given-names>Z.-G.</given-names>
          </name>
          <name>
            <surname>Kotamraju</surname>
            <given-names>V.R.</given-names>
          </name>
          <name>
            <surname>Sugahara</surname>
            <given-names>K.N.</given-names>
          </name>
          <name>
            <surname>Teesalu</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Ruoslahti</surname>
            <given-names>E.</given-names>
          </name>
        </person-group>
        <article-title>A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity</article-title>
        <source>J. Control. Release</source>
        <year>2014</year>
        <volume>175</volume>
        <fpage>48</fpage>
        <lpage>53</lpage>
        <pub-id pub-id-type="pmid">24345789</pub-id>
      </element-citation>
    </ref>
    <ref id="B42-pharmaceutics-14-00122">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rackovsky</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Scheraga</surname>
            <given-names>H.A.</given-names>
          </name>
        </person-group>
        <article-title>Hydrophobicity, hydrophilicity, and the radial and orientational distributions of residues in native proteins</article-title>
        <source>Proc. Natl. Acad. Sci. USA</source>
        <year>1977</year>
        <volume>74</volume>
        <fpage>5248</fpage>
        <lpage>5251</lpage>
        <pub-id pub-id-type="pmid">271950</pub-id>
      </element-citation>
    </ref>
    <ref id="B43-pharmaceutics-14-00122">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fukuchi</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Nishikawa</surname>
            <given-names>K.</given-names>
          </name>
        </person-group>
        <article-title>Protein surface amino acid compositions distinctively differ between thermophilic and mesophilic bacteria</article-title>
        <source>J. Mol. Biol.</source>
        <year>2001</year>
        <volume>309</volume>
        <fpage>835</fpage>
        <lpage>843</lpage>
        <pub-id pub-id-type="pmid">11399062</pub-id>
      </element-citation>
    </ref>
    <ref id="B44-pharmaceutics-14-00122">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Qian</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Sejnowski</surname>
            <given-names>T.J.</given-names>
          </name>
        </person-group>
        <article-title>Predicting the secondary structure of globular proteins using neural network models</article-title>
        <source>J. Mol. Biol.</source>
        <year>1988</year>
        <volume>202</volume>
        <fpage>865</fpage>
        <lpage>884</lpage>
        <pub-id pub-id-type="pmid">3172241</pub-id>
      </element-citation>
    </ref>
    <ref id="B45-pharmaceutics-14-00122">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nagpal</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Usmani</surname>
            <given-names>S.S.</given-names>
          </name>
          <name>
            <surname>Dhanda</surname>
            <given-names>S.K.</given-names>
          </name>
          <name>
            <surname>Kaur</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>G.P.</given-names>
          </name>
        </person-group>
        <article-title>Computer-aided designing of immunosuppressive peptides based on IL-10 inducing potential</article-title>
        <source>Sci. Rep.</source>
        <year>2017</year>
        <volume>7</volume>
        <fpage>42851</fpage>
        <pub-id pub-id-type="pmid">28211521</pub-id>
      </element-citation>
    </ref>
    <ref id="B46-pharmaceutics-14-00122">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Chaudhary</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Chauhan</surname>
            <given-names>J.S.</given-names>
          </name>
          <name>
            <surname>Nagpal</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>G.P.</given-names>
          </name>
        </person-group>
        <article-title>An in silico platform for predicting, screening and designing of antihypertensive peptides</article-title>
        <source>Sci. Rep.</source>
        <year>2015</year>
        <volume>5</volume>
        <fpage>12512</fpage>
        <pub-id pub-id-type="pmid">26213115</pub-id>
      </element-citation>
    </ref>
    <ref id="B47-pharmaceutics-14-00122">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chaudhary</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Tuknait</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Gautam</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Mathur</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Anand</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Varshney</surname>
            <given-names>G.C.</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>G.P.</given-names>
          </name>
        </person-group>
        <article-title>A web server and mobile app for computing hemolytic potency of peptides</article-title>
        <source>Sci. Rep.</source>
        <year>2016</year>
        <volume>6</volume>
        <fpage>22843</fpage>
        <pub-id pub-id-type="pmid">26953092</pub-id>
      </element-citation>
    </ref>
    <ref id="B48-pharmaceutics-14-00122">
      <label>48.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>McMeekin</surname>
            <given-names>T.L.</given-names>
          </name>
          <name>
            <surname>Groves</surname>
            <given-names>M.L.</given-names>
          </name>
          <name>
            <surname>Hipp</surname>
            <given-names>N.J.</given-names>
          </name>
        </person-group>
        <article-title>Refractive indices of amino acids, proteins, and related substances</article-title>
        <source>Amino Acids and Serum Proteins</source>
        <comment>Advances in Chemistry Series, No. 44</comment>
        <publisher-name>American Chemical Society</publisher-name>
        <publisher-loc>Washington, DC, USA</publisher-loc>
        <year>1964</year>
        <comment>Chapter 4</comment>
        <fpage>54</fpage>
        <lpage>66</lpage>
      </element-citation>
    </ref>
    <ref id="B49-pharmaceutics-14-00122">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Murata</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>K.-i.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Morita</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Dispersion of Complex Refractive Indices for Intense Vibrational Bands. I. Quantitative Spectra</article-title>
        <source>J. Phys. Chem. B</source>
        <year>2021</year>
        <volume>125</volume>
        <fpage>9794</fpage>
        <lpage>9803</lpage>
        <pub-id pub-id-type="pmid">34403590</pub-id>
      </element-citation>
    </ref>
    <ref id="B50-pharmaceutics-14-00122">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kuipers</surname>
            <given-names>B.J.</given-names>
          </name>
          <name>
            <surname>Gruppen</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>Prediction of molar extinction coefficients of proteins and peptides using UV absorption of the constituent amino acids at 214 nm to enable quantitative reverse phase high-performance liquid chromatography-mass spectrometry analysis</article-title>
        <source>J. Agric. Food Chem.</source>
        <year>2007</year>
        <volume>55</volume>
        <fpage>5445</fpage>
        <lpage>5451</lpage>
        <pub-id pub-id-type="pmid">17539659</pub-id>
      </element-citation>
    </ref>
    <ref id="B51-pharmaceutics-14-00122">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Lao</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Z.</given-names>
          </name>
        </person-group>
        <article-title>Development of a lytic peptide derived from BH3-only proteins</article-title>
        <source>Cell Death Discov.</source>
        <year>2016</year>
        <volume>2</volume>
        <fpage>16008</fpage>
        <pub-id pub-id-type="pmid">27551502</pub-id>
      </element-citation>
    </ref>
    <ref id="B52-pharmaceutics-14-00122">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xie</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Bi</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Teng</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>R.J.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Z.</given-names>
          </name>
        </person-group>
        <article-title>Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application</article-title>
        <source>Front. Pharm.</source>
        <year>2020</year>
        <volume>11</volume>
        <fpage>697</fpage>
      </element-citation>
    </ref>
  </ref-list>
</back>
<floats-group>
  <fig position="float" id="pharmaceutics-14-00122-f001">
    <label>Figure 1</label>
    <caption>
      <p>Schematic framework of the development of SCMTHP. This can be broken down to four major steps: (<bold>i</bold>) training and independent datasets preparation, (<bold>ii</bold>) SCMTHP-based propensity scores generation and optimization, (<bold>iii</bold>) THPs characterization and (<bold>iv</bold>) SCMTHP webserver construction.</p>
    </caption>
    <graphic xlink:href="pharmaceutics-14-00122-g001" position="float"/>
  </fig>
  <fig position="float" id="pharmaceutics-14-00122-f002">
    <label>Figure 2</label>
    <caption>
      <p>Propensity scores of 20 amino acids to be THPs by using the SCMTHP method with the Main (<bold>A</bold>) and Small (<bold>B</bold>) datasets.</p>
    </caption>
    <graphic xlink:href="pharmaceutics-14-00122-g002" position="float"/>
  </fig>
  <fig position="float" id="pharmaceutics-14-00122-f003">
    <label>Figure 3</label>
    <caption>
      <p>Performance evaluations of SCMTHP and other ML-based classifiers in terms of ACC and MCC as evaluated by 10-fold cross-validation (<bold>A</bold>,<bold>B</bold>) and independent (<bold>C</bold>,<bold>D</bold>) tests on the Main-TRN and Main-IND datasets, respectively.</p>
    </caption>
    <graphic xlink:href="pharmaceutics-14-00122-g003" position="float"/>
  </fig>
  <fig position="float" id="pharmaceutics-14-00122-f004">
    <label>Figure 4</label>
    <caption>
      <p>Histogram plots of THPs’ scores and non-THPs’ scores from SCMTHP on the Main-TRN (<bold>A</bold>,<bold>B</bold>) and Small-TRN (<bold>C</bold>,<bold>D</bold>) datasets by using Initial-APS (<bold>A</bold>,<bold>C</bold>) and Optimized-APS (<bold>B</bold>,<bold>D</bold>). Note that the mean and standard deviation are indicated by the bars and closed circles.</p>
    </caption>
    <graphic xlink:href="pharmaceutics-14-00122-g004" position="float"/>
  </fig>
  <table-wrap position="float" id="pharmaceutics-14-00122-t001">
    <object-id pub-id-type="pii">pharmaceutics-14-00122-t001_Table 1</object-id>
    <label>Table 1</label>
    <caption>
      <p>Performance comparison of SCMTHP with the existing method as evaluated by 10-fold cross-validation and independent tests.</p>
    </caption>
    <table frame="hsides" rules="groups">
      <thead>
        <tr>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dataset</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cross-Validation</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Method</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ACC</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sn</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sp</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MCC</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">AUC</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Main</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">10-fold CV</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">THPred</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.857</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.877</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.837</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.716</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.929</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SCMTHP</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.820</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.819</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.820</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.641</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.869</td>
        </tr>
        <tr>
          <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Independent test</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">THPred</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.846</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.792</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.900</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.696</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.939</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SCMTHP</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.827</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.869</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.785</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.656</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.869</td>
        </tr>
        <tr>
          <td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Small</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">10-fold CV</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">THPred</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.824</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.781</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.867</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.653</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.893</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SCMTHP</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.808</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.723</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.893</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.628</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.853</td>
        </tr>
        <tr>
          <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Independent test</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">THPred</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.798</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.862</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.734</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.601</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.885</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SCMTHP</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.798</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.766</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.830</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.597</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.853</td>
        </tr>
      </tbody>
    </table>
  </table-wrap>
  <table-wrap position="float" id="pharmaceutics-14-00122-t002">
    <object-id pub-id-type="pii">pharmaceutics-14-00122-t002_Table 2</object-id>
    <label>Table 2</label>
    <caption>
      <p>Top 20 peptides having the highest S(P) values along with their important physicochemical properties.</p>
    </caption>
    <table frame="hsides" rules="groups">
      <thead>
        <tr>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">#</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sequence</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">THP Score</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Length</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Molecular Weight </th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extinction Coefficient (M<sup>−1</sup>·cm<sup>−1</sup>)</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">pI</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Net Charge</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hydrophobicity (Kcal·mol<sup>−1</sup>)</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">CFWPNRC</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">684</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">925.17</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5625</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.30</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6.86</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">2</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">QWCSRRWCT</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">657</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1225.52</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11125</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.93</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.78</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">3</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">WTCRASWCS</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">632</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1099.35</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11125</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.25</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7.16</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">4</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">SGWCYRC</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">631</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">874.08</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7115</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.21</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.48</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">5</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">RWCREKSCW</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">631</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1253.57</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11125</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.85</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">14.19</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">6</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">CSDWQHPWC</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">627</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1161.39</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11125</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">4.97</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11.02</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">7</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">CPRGSRC</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">621</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">777.99</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">125</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9.66</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">13.23</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">8</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">CWRKFYC</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">617</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1005.3</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7115</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9.24</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7.96</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">CSDSWHYWC</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">615</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1186.39</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">12615</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">4.97</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9.86</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">10</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">WRPCES</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">607</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">776.93</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5500</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6.16</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11.83</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">11</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">CWLCNGRCGR</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">606</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">10</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1167.52</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5625</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.60</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11.27</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">12</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">RHCFSQWCS</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">600</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1153.41</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5625</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.19</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9.89</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">13</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">CDCRGDCFC</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">598</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1021.26</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">250</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.91</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">16.35</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">14</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">CPHSKPCLC</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">598</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">987.33</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">125</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.01</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">12.46</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">15</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">CWGCNGRCRM</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">595</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">10</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1185.55</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5625</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.60</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11.85</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">16</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">CSRPRRSEC</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">585</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1093.34</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">125</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9.65</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">17.98</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">17</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">CSRPRRSVC</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">583</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1063.36</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">125</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11.33</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">13.89</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">18</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">CVLCNGRCWS</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">576</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">10</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1140.49</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5625</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.00</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.31</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">19</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">CRGDGWC</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">571</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">795.97</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5625</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5.94</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">13.52</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WREWFL</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">571</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">936.16</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11000</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.70</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.20</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">610.25</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1041.50</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6117.25</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.82</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.00</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.05</td>
        </tr>
      </tbody>
    </table>
  </table-wrap>
  <table-wrap position="float" id="pharmaceutics-14-00122-t003">
    <object-id pub-id-type="pii">pharmaceutics-14-00122-t003_Table 3</object-id>
    <label>Table 3</label>
    <caption>
      <p>Top 20 peptides having the lowest S(P) values along with their important physicochemical properties.</p>
    </caption>
    <table frame="hsides" rules="groups">
      <thead>
        <tr>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">#</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sequence</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">THP Score</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Length</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Molecular Weight </th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extinction Coefficient (M<sup>−1</sup>·cm<sup>−1</sup>)</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">pI</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Net Charge</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hydrophobicity (Kcal·mol<sup>−1</sup>)</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">IKIQD</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">69</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">615.80</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6.72</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">12.87</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">2</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">KKEKDIMKKTI</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">74</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1361.87</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">10.39</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">26.51</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">3</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">INGKVT</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">99</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">630.83</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">10.15</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11.37</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">4</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">VKNNVEVN</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">105</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">915.13</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6.81</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">15.50</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">5</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">IGIGAG</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">105</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">486.66</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5.60</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9.61</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">6</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">AVKKAYDIAIQ</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">108</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1219.60</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1490</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9.73</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">16.00</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">7</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">DVGTTE</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">113</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">620.69</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2.87</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−2</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">16.36</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">8</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">IGDAT</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">114</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">475.56</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.00</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">12.32</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">VAIDM</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">115</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">547.73</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.02</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9.79</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">10</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">DVKGVFVNI</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">119</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">990.30</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6.77</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">12.13</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">11</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">DLAVVEVDQVMVVD</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">119</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">14</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1530.96</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2.63</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−4</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">19.04</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">12</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">TDIDDKIINRAI</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">121</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">12</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1386.74</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">4.21</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">20.55</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">13</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">GDVVANT</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">123</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">674.80</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.00</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">13.37</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">14</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">IDKQLE</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">131</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">744.93</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7.00</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">16.37</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">15</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">FGKKKKYKD</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">131</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1141.50</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1490</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">10.49</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">4</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">24.27</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">16</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">KENILNE</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">135</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">859.05</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">4.08</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">17.29</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">17</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">HEAVGI</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">136</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">624.78</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5.06</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−1</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">13.93</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">18</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">HKNKGKKN</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">139</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">953.23</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11.03</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">4</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">24.28</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">19</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">ENAKAAVAEMKDGDVVLLE</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">139</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">19</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2002.54</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.84</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−3</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">31.12</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ITDMAA</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">140</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">620.79</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.13</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−1</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.00</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">116.75</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">920.17</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">149.00</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.98</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.20</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.68</td>
        </tr>
      </tbody>
    </table>
  </table-wrap>
  <table-wrap position="float" id="pharmaceutics-14-00122-t004">
    <object-id pub-id-type="pii">pharmaceutics-14-00122-t004_Table 4</object-id>
    <label>Table 4</label>
    <caption>
      <p>Propensity scores of 20 amino acids to be THPs (PS-THP) along with amino acid compositions (%) of THPs and non-THPs based on the Main-TRN dataset.</p>
    </caption>
    <table frame="hsides" rules="groups">
      <thead>
        <tr>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Amino Acid</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PS-THP</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">THP (%)</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">non-THP (%)</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Difference</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">C-Cys</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1000(1)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9.635</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1.082</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.552(1)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01 *</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">W-Trp</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">981(2)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.459</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1.088</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2.371(3)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01 *</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">R-Arg</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">598(3)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.947</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5.062</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.885(2)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01 *</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">P-Pro</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">587(4)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6.831</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">4.940</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1.891(4)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01 *</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">F-Phe</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">424(5)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.018</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.846</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−0.828(13)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.017</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">S-Ser</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">407(6)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.525</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6.860</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1.666(5)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01 *</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">H-His</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">382(7)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.084</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2.699</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.385(6)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.287</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">L-Leu</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">374(8)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.157</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">9.394</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−1.237(14)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.020</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">Y-Tyr</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">273(9)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.023</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2.912</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.111(8)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.741</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">M-Met</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">266(10)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2.629</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">2.604</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.025(9)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.940</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">Q-Gln</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">198(11)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.284</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">4.052</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−0.769(11)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.046</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">N-Asn</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">195(12)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.365</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">4.169</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−0.804(12)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.033</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">A-Ala</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">160(13)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5.717</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">8.099</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−2.382(16)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01 *</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">G-Gly</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">157(14)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7.552</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">7.203</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.349(7)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.516</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">T-Thr</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">150(15)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">4.744</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5.364</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−0.620(10)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0.186</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">D-Asp</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">103(16)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.798</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5.664</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−1.866(15)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01 *</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">E-Glu</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">67(17)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.544</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6.153</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−2.609(19)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01 *</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">V-Val</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">48(18)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">4.392</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6.906</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−2.514(17)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01 *</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">K-Lys</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">45(19)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">3.469</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6.008</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">−2.540(18)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.01 *</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I-Ile</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0(20)</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.828</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.894</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−3.066(20)</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.01 *</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.000</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.462</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.589</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.876</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
        </tr>
      </tbody>
    </table>
    <table-wrap-foot>
      <fn>
        <p>* Statistically significant at the level of <italic toggle="yes">p</italic>-value &lt; 0.01.</p>
      </fn>
    </table-wrap-foot>
  </table-wrap>
  <table-wrap position="float" id="pharmaceutics-14-00122-t005">
    <object-id pub-id-type="pii">pharmaceutics-14-00122-t005_Table 5</object-id>
    <label>Table 5</label>
    <caption>
      <p>Summary of two important physicochemical properties (PCPs) as derived from SCMTHP.</p>
    </caption>
    <table frame="hsides" rules="groups">
      <thead>
        <tr>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Amino Acid</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PS-THP</th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MCMT640101 <sup>a</sup></th>
          <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Molar Extinction Coefficients
<inline-formula><mml:math id="mm26" overflow="scroll"><mml:mrow><mml:mstyle mathvariant="bold"><mml:mrow><mml:mo>(</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi mathvariant="bold-italic">ε</mml:mi></mml:mstyle><mml:mo> </mml:mo><mml:mo>(</mml:mo><mml:msup><mml:mi mathvariant="bold">M</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo> </mml:mo><mml:msup><mml:mi mathvariant="bold">cm</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>)</mml:mo><mml:mo>)</mml:mo><mml:msup><mml:mo> </mml:mo><mml:mi mathvariant="bold">b</mml:mi></mml:msup></mml:mrow></mml:mstyle></mml:mrow></mml:math></inline-formula>
</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">C-Cys</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">1000(1)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">35.77(2)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">225(6)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">W-Trp</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">981(2)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">42.53(1)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">29,050(1)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">R-Arg</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">598(3)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">26.66(5)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">102(9)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">P-Pro</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">587(4)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">10.93(17)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">30(19)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">F-Phe</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">424(5)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">29.4(4)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5200(3)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">S-Ser</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">407(6)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">6.35(18)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">34(17)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">H-His</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">382(7)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">21.81(6)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5125(4)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">L-Leu</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">374(8)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">18.78(10)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">45(13)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">Y-Tyr</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">273(9)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">31.53(3)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">5375(2)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">M-Met</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">266(10)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">21.64(7)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">980(5)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">Q-Gln</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">198(11)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">17.56(11)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">142(7)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">N-Asn</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">195(12)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">13.28(14)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">136(8)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">A-Ala</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">160(13)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">4.34(19)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">32(18)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">G-Gly</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">157(14)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">0(20)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">21(20)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">T-Thr</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">150(15)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">11.01(16)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">41(16)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">D-Asp</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">103(16)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">12(15)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">58(11)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">E-Glu</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">67(17)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">17.26(12)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">78(10)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">V-Val</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">48(18)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">13.92(13)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">43(14)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">K-Lys</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">45(19)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">21.29(8)</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">41(15)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I-Ile</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0(20)</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.06(9)</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45(12)</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.000</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.635</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.556</td>
        </tr>
      </tbody>
    </table>
    <table-wrap-foot>
      <fn>
        <p><sup>a</sup> MCMT640101 = Refractivity (McMeekin et al., 1964) [<xref rid="B18-pharmaceutics-14-00122" ref-type="bibr">18</xref>], Cited by Jones (1975) [<xref rid="B18-pharmaceutics-14-00122" ref-type="bibr">18</xref>]. <sup>b</sup>
<inline-formula><mml:math id="mm27" overflow="scroll"><mml:mrow><mml:mi mathvariant="sans-serif">ε</mml:mi></mml:mrow></mml:math></inline-formula> (M<sup>−1</sup> cm<sup>−1</sup>) <sup>c</sup> = Molar extinction coefficients (<inline-formula><mml:math id="mm28" overflow="scroll"><mml:mrow><mml:mi mathvariant="sans-serif">ε</mml:mi></mml:mrow></mml:math></inline-formula>) of free amino acids (M<sup>−1</sup> cm<sup>−1</sup>) at 214 nm in 20% (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) acetonitrile and 0.1% (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) formic acid derived from the work of [<xref rid="B50-pharmaceutics-14-00122" ref-type="bibr">50</xref>].</p>
      </fn>
    </table-wrap-foot>
  </table-wrap>
</floats-group>
